<SEC-DOCUMENT>0001828316-24-000033.txt : 20241010
<SEC-HEADER>0001828316-24-000033.hdr.sgml : 20241010
<ACCEPTANCE-DATETIME>20241010060604
ACCESSION NUMBER:		0001828316-24-000033
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20241010
FILED AS OF DATE:		20241010
DATE AS OF CHANGE:		20241010

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pharming Group N.V.
		CENTRAL INDEX KEY:			0001828316
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39822
		FILM NUMBER:		241363738

	BUSINESS ADDRESS:	
		STREET 1:		DARWINWEG 24
		CITY:			LEIDEN
		STATE:			P7
		ZIP:			2333 CR
		BUSINESS PHONE:		31 (0)71 5247 400

	MAIL ADDRESS:	
		STREET 1:		DARWINWEG 24
		CITY:			LEIDEN
		STATE:			P7
		ZIP:			2333 CR

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pharming Group Group N.V.
		DATE OF NAME CHANGE:	20201014
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>pharminggroupannouncesstrt.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i7e14e049c807407c86bd0f28421af756_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Washington, D.C. 20549</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">FORM 6-K</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">PURSUANT TO RULE 13a-16 OR 15d-16</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">For the Month of October</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Commission File Number&#58; 001-39822</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">Pharming Group N.V.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Exact Name of Registrant as Specified in Its Charter)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Darwinweg 24</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2333 CR Leiden</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">The Netherlands</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Address of principal executive offices)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form 20-F </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9746;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">           Form 40-F </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furnished as Exhibit 99.1 to this Report on Form 6-K is a press release of Pharming Group N.V., or the Company, dated October 10, 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">EXHIBIT INDEX</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:14.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit No.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Description</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">99.1</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.403%"><tr><td style="width:1.0%"></td><td style="width:27.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pharming Group N.V.</font></div></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;s&#47; Sijmen de Vries</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sijmen de Vries</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Title&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">CEO</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date&#58; October 10, 2024</font></div><div id="i7e14e049c807407c86bd0f28421af756_4"></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginala.jpg" src="logo_pharmingxoriginala.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="text-align:center"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:18pt;font-weight:700;line-height:115%">Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation</font></div><div style="text-align:center"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Proof of concept clinical trial will evaluate leniolisib in PIDs with immune dysregulation linked to altered PI3K&#7839; signaling in lymphocytes</font></div><div style="text-align:center"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%"><br>PIDs to include ALPS-FAS, CTLA4 haploinsufficiency, NFKB1 haploinsufficiency and PTEN deficiency, with prevalence approximately five times that of APDS</font></div><div style="text-align:center"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%"><br>Clinical trial being conducted at the National Institutes of Health (NIH)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Leiden, the Netherlands, October 10, 2024&#58;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> Pharming Group N.V. (&#8220;Pharming&#8221; or &#8220;the Company&#8221;) (Euronext Amsterdam&#58; PHARM &#47; Nasdaq&#58; PHAR) &#58; Pharming Group N.V. (&#8220;Pharming&#8221; or &#8220;the Company&#8221;) (EURONEXT Amsterdam&#58; PHARM&#47;Nasdaq&#58; PHAR) announces the start of a Phase II, proof of concept, clinical trial evaluating leniolisib in primary immunodeficiencies (PIDs) with immune dysregulation linked to altered PI3K&#7839; signaling in lymphocytes.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The clinical trial is open for enrollment and will include PID patients with ALPS-FAS, CTLA4 haploinsufficiency, NFKB1 haploinsufficiency and PTEN deficiency, among others. These PID patients exhibit altered PI3K&#7839; signaling in lymphocytes and likewise display similar clinical phenotypes to activated phosphoinositide 3-kinase delta syndrome (APDS) patients. Epidemiology suggests a prevalence of approximately seven patients per million in this targeted PID population, compared to one to two patients per million for APDS.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Phase II clinical trial is a single arm, open-label, dose range-finding study to be conducted in approximately 12 patients. The objectives for the trial will be to assess safety and tolerability, pharmacokinetics, pharmacodynamics, and explore clinical efficacy of leniolisib in the targeted PID population. The trial has been designed to inform a subsequent Phase III program. The Phase II clinical trial is being conducted at the National Institute of Allergy and Infectious Diseases (NIAID) &#8211; part of the National Institutes of Health (NIH) &#8211; with lead investigator Gulbu Uzel, M.D., Senior Research Physician, and co-investigator V. Koneti Rao, M.D., FRCPA, Senior Research Physician, Primary Immune Deficiency Clinic (ALPS Clinic). </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Anurag Relan, MD, MPH, Chief Medical Officer of Pharming, commented&#58;</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;The initiation of this study is an important milestone for Pharming as it represents the second primary immunodeficiency (PID) clinical program for leniolisib. Based on our experience in APDS, and the significant role of PI3Kd in regulating lymphocytes, leniolisib has the potential to address the underlying immune dysregulation and deficiency in a number of rare PID disorders with significant unmet medical needs, including ALPS-FAS, CTLA4 haploinsufficiency, NFKB1 haploinsufficiency and PTEN deficiency. We are excited to be leading this important scientific effort and to sharing the results of the study with the medical community.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The first patient is expected to be enrolled in the study in the coming weeks.<br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginala.jpg" src="logo_pharmingxoriginala.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This is the first clinical trial initiated by Pharming to study leniolisib in PIDs with immune dysregulation beyond APDS. The unique genetic drivers in ALPS-FAS, CTLA4 haploinsufficiency, NFKB1 haploinsufficiency and PTEN patients lead to enhanced PI3Kd signaling and clinical phenotypes of immune dysregulation shared with APDS. Specifically, PTEN patients with immunodeficiency are frequently described as &#8216;APDS-like&#8217;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, patients with ALPS-FAS display predominantly lymphoproliferative clinical manifestations with frequent cytopenic episodes</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and CTLA4 haploinsufficiency</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> as well as NFKB1 haploinsufficiency</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> patients demonstrate lymphoproliferative, cytopenic, and&#47;or organ-specific autoimmune&#47;inflammatory complications of immune dysregulation.<br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Leniolisib is marketed in the U.S. and approved in several other countries, for the treatment of APDS in adult and pediatric patients 12 years of age and older.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About leniolisib</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Leniolisib is an oral small molecule phosphoinositide 3-kinase delta (PI3K&#7839;) inhibitor approved in the U.S. and several other countries as the first and only targeted treatment of activated phosphoinositide 3-kinase delta (PI3K&#948;) syndrome (APDS) in adult and pediatric patients 12 years of age and older. Leniolisib inhibits the production of phosphatidylinositol-3-4-5-trisphosphate, which serves as an important cellular messenger and regulates a multitude of cell functions such as proliferation, differentiation, cytokine production, cell survival, angiogenesis, and metabolism. Results from a randomized, placebo-controlled Phase III clinical trial demonstrated statistically significant improvement in the coprimary endpoints, reflecting a favorable impact on the immune dysregulation and deficiency seen in these patients, and interim open label extension data has supported the safety and tolerability of long-term leniolisib administration.</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">5,6</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Leniolisib is currently under regulatory review in the European Economic Area, Canada and Australia for APDS, with plans to pursue further regulatory approvals in Japan and South Korea. Leniolisib is also being evaluated in two Phase III clinical trials in children with APDS and in a Phase II clinical trial in primary immunodeficiencies (PIDs) with immune dysregulation linked to altered PI3K&#7839; signaling in lymphocytes. The safety and efficacy of leniolisib has not been established for PIDs with immune dysregulation beyond APDS.</font></div><div><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Pharming Group N.V.  </font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pharming Group N.V. (EURONEXT Amsterdam&#58; PHARM&#47;Nasdaq&#58; PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For more information, visit www.pharming.com and find us on LinkedIn.  </font></div><div><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward-Looking Statements&#8239;&#8239; </font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">This press release may contain forward-looking statements. Forward-looking statements are statements of future expectations that are based on management&#8217;s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in these statements. These forward-looking statements are identified by their use of terms and phrases such as &#8220;aim&#8221;, &#8220;ambition&#8221;, &#8216;&#8216;anticipate&#8217;&#8217;, &#8216;&#8216;believe&#8217;&#8217;, &#8216;&#8216;could&#8217;&#8217;, &#8216;&#8216;estimate&#8217;&#8217;, &#8216;&#8216;expect&#8217;&#8217;, &#8216;&#8216;goals&#8217;&#8217;, &#8216;&#8216;intend&#8217;&#8217;, &#8216;&#8216;may&#8217;&#8217;, &#8220;milestones&#8221;, &#8216;&#8216;objectives&#8217;&#8217;, &#8216;&#8216;outlook&#8217;&#8217;, &#8216;&#8216;plan&#8217;&#8217;, &#8216;&#8216;probably&#8217;&#8217;, &#8216;&#8216;project&#8217;&#8217;, &#8216;&#8216;risks&#8217;&#8217;, &#8220;schedule&#8221;, &#8216;&#8216;seek&#8217;&#8217;, &#8216;&#8216;should&#8217;&#8217;, &#8216;&#8216;target&#8217;&#8217;, &#8216;&#8216;will&#8217;&#8217; and similar terms and phrases. Examples of forward-looking statements may include statements with respect </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_greyxoriginalxa.jpg" src="logo_greyxoriginalxa.jpg" style="height:48px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">to timing and progress of Pharming's preclinical studies and clinical trials of its product candidates, Pharming's clinical and commercial prospects, and Pharming's expectations regarding its projected working capital requirements and cash resources, which statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to the scope, progress and expansion of Pharming's clinical trials and ramifications for the cost thereof&#59; and clinical, scientific, regulatory, commercial, competitive and technical developments. In light of these risks and uncertainties, and other risks and uncertainties that are described in Pharming's 2023 Annual Report and the Annual Report on Form 20-F for the year ended December 31, 2023, filed with the U.S. Securities and Exchange Commission, the events and circumstances discussed in such forward-looking statements may not occur, and Pharming's actual results could differ materially and adversely from those anticipated or implied thereby. All forward-looking statements contained in this press release are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Any forward-looking statements speak only as of the date of this press release and are based on information available to Pharming as of the date of this release. Pharming does not undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information.</font></div><div><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">References</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.43pt">Tsujita Y, et al. J Allergy Clin Immunol 2016&#59;138&#58;1672-80.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.43pt">Bride K &#38; Teachey D. F1000Res. 2017&#59;6&#58;1928.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.43pt">Kuehn HS, et al. Science 2014&#59;345&#58;1623-27.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.43pt">Lorenzini T, et al. J Allergy Clin Immunol 2020&#59;146&#58;901-11.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.43pt">Rao VK, et al Blood. 2023 Mar 2&#59;141(9)&#58;971-983.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.43pt">Rao VK, et al.  J Allergy Clin Immunol 2024&#59;153&#58;265-74.</font></div><div><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For further public information, contact&#58;</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Pharming Group, Leiden, the Netherlands</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Michael Levitan, VP Investor Relations &#38; Corporate Communications<br>T&#58; +1 (908) 705 1696</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">E&#58; investor&#64;pharming.com</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">FTI Consulting, London, UK</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Victoria Foster Mitchell&#47;Alex Shaw&#47;Amy Byrne<br>T&#58; +44 203 727 1000</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">LifeSpring Life Sciences Communication, Amsterdam, the Netherlands</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Leon Melens<br>T&#58; +31 6 53 81 64 27<br>E&#58; pharming&#64;lifespring.nl</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">US PR</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Christina Renfroe<br>T&#58; +1 (636) 352-7883</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">E&#58; Christina.Renfroe&#64;precisionaq.com </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo_greyxoriginalxa.jpg
<TEXT>
begin 644 logo_greyxoriginalxa.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^$Q3FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI
M2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN
M<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0($-O<F4@-2XV+6,Q-#,@-SDN
M,38Q,C$P+" R,#$W+S X+S$Q+3$P.C(X.C,V(" @(" @(" B/@H@(" \<F1F
M.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M
M<F1F+7-Y;G1A>"UN<R,B/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G
M+V1C+V5L96UE;G1S+S$N,2\B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z
M>&UP1TEM9STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(*
M(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @
M(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(@H@(" @(" @(" @("!X;6QN<SII
M;&QU<W1R871O<CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]I;&QU<W1R871O<B\Q
M+C O(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC
M;VTO<&1F+S$N,R\B/@H@(" @(" @(" \9&,Z9F]R;6%T/FEM86=E+VIP96<\
M+V1C.F9O<FUA=#X*(" @(" @(" @/&1C.G1I=&QE/@H@(" @(" @(" @(" \
M<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB>"UD
M969A=6QT(CY,;V=O7V=R97E?;W)I9VEN86Q?PJX\+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @
M(" \>&UP.DUE=&%D871A1&%T93XR,#$Y+3 Q+3 Y5#$T.C0X.C,V*S Q.C P
M/"]X;7 Z365T861A=&%$871E/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^
M,C Q.2TP,2TP.50Q,SHT.#HS.5H\+WAM<#I-;V1I9GE$871E/@H@(" @(" @
M(" \>&UP.D-R96%T941A=&4^,C Q.2TP,2TP.50Q-#HT.#HS-BLP,3HP,#PO
M>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^061O
M8F4@26QL=7-T<F%T;W(@0T,@,C(N," H36%C:6YT;W-H*3PO>&UP.D-R96%T
M;W)4;V]L/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @
M(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED
M=&@^,C4V/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP
M1TEM9SIH96EG:'0^-C0\+WAM<$=);6<Z:&5I9VAT/@H@(" @(" @(" @(" @
M(" @(" \>&UP1TEM9SIF;W)M870^2E!%1SPO>&UP1TEM9SIF;W)M870^"B @
M(" @(" @(" @(" @(" @(#QX;7!'26UG.FEM86=E/B\Y:B\T04%14VM:2E)G
M04)!9T5"3$%%<T%!1"\W44%S54=H=F1'.7IA1SEW241-=4U!0311:VQ.02LP
M04%!04%!0D%"3$%!04%!14$F(WA!.T%117-!04%!05%!0B\K-$%$:T9K8C)*
M;$%'5$%!04%!068O8D%)44%"9U%%0D%514)G549"9VM'0E%92D-W9T="9V=,
M1$%O2T-W;TLF(WA!.T1"04U$07=-1$%W441!-%!%03A/1$)-5$9"451%>'=B
M1WAS8TAX.&9(>#AF2'@X9DAW14A"=V-.1$$P645"05E':%521E)O9DAX.&8F
M(WA!.TAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF2'@X9DAX.&9(>#AF2'@X9B\X04%%46=!44%%04%W15(F(WA!.T%!25)!
M44U2068O14%A24%!04%(05%%0D%114%!04%!04%!04%!449!=TE'05%!2$-!
M:TM#=T5!06=)1$%114)!445!04%!04%!04$F(WA!.T%104-!=U%&0F=C24-1
M;TQ%04%#05%-1$%G44-"9V-$0D%)1T%N34)!9TU20D%!1DE227A15D5'13)%
M:6-9155-<$=H0GA7>%%I4$(F(WA!.U5T2&A->%II.$-2>6=V16Q1>E)4:W%+
M>5DS4$-.55%N:S9/>DYH9%5:2%1$,'5)24IO34I#:&=::$I21E)Q4S!6=$Y6
M2T)R>30O4$4F(WA!.S%/5#!:6%=&;&%7,7AD6&PY5UHR:'!A;71S8E<U=EDS
M4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\K0VLU4U9L<&59;5HF
M(WA!.W%B;DHR96XU2VIP2U=M<#9I<'%Q=7-R839V;U)!04E#05%)1$)1545"
M45E%0T%-1&)114%!:$5$0D-%4TU514954DYH26=:>&=:17DF(WA!.V]B2'=&
M34A2-%-.0T962FEC=D5Z2D121&=H85-5>5=I63=,0T(S4%-.94I%9WAD56MW
M9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y9W F(WA!.S K4'IH2E-K=$U45350
M4FQD65=6<&)81C%E6#%2;%IM9&]A5W!R8D<Q=6(R4C%D;F0T95AP-V9(,2MF
M,T]%:%EA2&E);4MI-'E.:F\F(WA!.RM$;$I75VPU:5IM<'5C;EHV9FMQ3VMP
M86%N<4MM<7$V>71R<2MV+V%!07=$05%!0T5135)!1#A!.54T<3=&5U!E9"]/
M*VME571)82LF(WA!.W9M-7IV5F)/>E4P:VUK2%EE0VHY<'4S>F]-=7=91&M.
M0G)Y-5)!5UAY>C5L.'HV>C5J,4]45615;F%75GEF5&IQ9E1J6'-K83E&568F
M(WA!.S=E*V(O2&EJ055(5%I-:&UB3#!4.'%0>F=N,'%A4%)F354W4S9825%T
M=&5Y17,Q=65G5GED>D@O04U2*UA40S%E:C1V5DAM-65N,4XF(WA!.V)3-5!O
M1T]33U=.6DDR1'AU07E/<$)6;$EQ0T-/;T]A8V@R4S=&6%EQ-T9867$W1EA9
M<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$F(WA!.S=&6%EQ-T9867$W1EA9
M<3=&6%EQ-T9867$W1E5I.#5E8W1).'%A3RMO-F<Q5TY6=&):5"LX;6MP<W$K
M,VEE,E<T8TIY4V].951)24,F(WA!.WDK5U!.9FUR5F9-*W-Y-G!Q5#%K9C19
M;VQR=VEJ2#)544AS4'A/*V(O1FE%23!(5#5C:&UB2U1:63%V5%!Y-2]+:4Q6
M-T)V35!M4U(F(WA!.S=045EW5VA25'AK;G S<E$P4W4R,C=D=DA-4%!Q:41W
M43-K-65(5&=J:6YT1C94<%AN5%)T0W19.4TP9E1*1C!Y16XP>$QC3S=!12\F
M(WA!.W,K<#9N160K4$MM55,P37 W>6PV=F-Y1W1J2&%),CDW3V1',75X,64P
M1GIA3G-.<$DR,F1'.$='82],:&QJ3D9Z.%=55$9H2#55,D\F(WA!.WA6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+<% U<S@Q858U63!A6%9.4F4F(WA!.VMA9D1&0W!(3U=1+UI2
M064U+T%B-6)I>$A*2V=W>5I"05=8>78U>#@T-G8U<C%D.5(Q1C9+2W)B5WEK
M*VY$2%@W2R]X4&9..6AW>'@F(WA!.WAO3VYY-51-,E5I>3%Q96PO;%@K5TU7
M<W%F35!M1#EX-65T5'E62'%V,6QL3RLO*RMW9&E2,4]W-S5H86Y5;5!O:CE2
M8W9"9T(Y578F(WA!.W!:<C5M.'EV<6MQ,CEU=F]A6&)F1&)7-FII2TM+0FE"
M=# V1'1K.5!P>$%79G%,5'%.45IM:#E,1W(O54Q7=W17=6)L*T5A+V5X-TLF
M(WA!.V\W:S5K=4]L,VPS.#%2<#)Q3$Q&1SEU:%!%<WA$;WDQ-E-+2V)F3'!L
M95A#2FEI,C1P>6=B1#9*,'952612,#8S=F]F-W$T:E=29#8F(WA!.S!Q3VQ2
M-%IZ*U-(1$EJ=60U0UA%0556:T=4>%A39GIM."\V=S!Q-E@U9F=V5VA!36]H
M4UHK26%T2S!B=E1&56)0*V%N-6LV9D=B;E4F(WA!.R]+5$I:;TMY3T5N:D%(
M:5A0<4)F<$=+<S4X:V5F3D@X,U=,>E=184<U9V],<7IK<'I4;#!)23):5%19
M-'%K+VPW.'=T4S%0.'=T5#@F(WA!.W-Y,C!+5VQI2B]4;E1N-FIE:S9Q2S%0
M2&9L-%EQ>GI&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1E=+9FU(-390:R]4
M8F$X1FDQ.&(F(WA!.VUB,'%C+U16841L571X9F,P,D9-5EI(<'0U.60P-C%V
M4%1A2#9Z1$A.-E0W36YQ2T<T=#=I=$1I<4EX5C)+=7A6,DMU>%9J9FTO>F8F
M(WA!.THU9F$P0U=N,7(Q,F\T-3A#1G%".$DT=%AR=C1B94]+=FUN>GHU,3%4
M>F)R56PY9'56=&M,3%DR;U!W4E)6,DAU>"]A8G8X04MG>F\F(WA!.W-'15DT
M,$A36G-P;6)9-6QZ53E&+TLS.'-Z<CAP,7)79UE03&1O4WIS>#1F5T=4<7%N
M*U%F=$XY03,V665P,5!$-EDO5UA+,"M$:3DF(WA!.U5V<%HY-6XX>4QQ3$I:
M5TMF5CE)=%%%=#1&05)31C)"-&IO05!S:G1H,#)N-$YZ.5)A.51Q3TTP4'!9
M>F4S='9:5WHS3G<S0TM-5E F(WA!.VE4,D$Y>FU5-'IZ5%A.8W5D5G5F56LK
M0T)+:4=%2%I2-&YX2G=S9T5T>%,Y9B])1'IF<6ME=$AY>DTW5&%B8U)Y4S(V
M3E4K:DEG-4@F(WA!.VEE>7-+,4AJ.4YD9'(X231E4'$U,FIY;2M(;SDK>E5/
M>65*9C@T-F8W,38U+W=!63=F.$$T;$II<C(P9T5%159",DE/2W9$=DE58T8F
M(WA!.VPK9&5Q5VUL54=N,74T,U).:U9!43-%1'=744)2:7%74F5:,SAU+VUX
M-6=V26)/4R]U-7!,:3)T3%-0<3AS:W$X46%!;6YW.6A81E<F(WA!.U%A<C4X
M+T]B4F]2<75Q84QB>&%B56,P-&-L54UA1&M5;%HP.$MT:7(P=GEF-6YT9DTR
M9U<R<C(V1TPQ<7),0U15>'E)84UT9'$K>#@F(WA!.TU665 U9R].8E<W<GI$
M2C5D.&QA96UO6&M*6DIR;5=P5&Q'85!W2$M.47%N8FUZ52]!;%9,-VHX>79Z
M3#AR6$9U+VTO4F]J<#@W8V8F(WA!.U5I-&@V.6%,2D<X:V9+;2]&:'9I<C%A
M2%5O8G)353%+>4)U65IO0F-7>7)S,&ES;DY12SE#,W9I<GEA,2]05%9B+U-X
M8F%D<$@Q:GHF(WA!.TI.339W,CAA=DI%<U R;&-H9FI:9T1X23EU5S-41E=5
M85 U;#@X5R]K;E<Y5SAW,F%7*W%70WEY5VM4>&Q56D5J1$QY0W1U3U92<U(F
M(WA!.VER1TY%+TYR.'=034YN.5<P5%%O8G)655EM-'5&1$QB4GAN-T%O.&XR
M:G8Y<"]O>%9B0BMB6&Y8>3ER559H-3$P>$ER95=H85-.3TTF(WA!.VEQ5%1M
M:%9N:FM!-V=F9FEQ3&LX*R]M;#5G5C<S>7!O4W@V3T-21%!/13E344$P-40Q
M2%)4.&M"*UIX5DTO>3<O3D153F(Q:69Y+W(F(WA!.SEM=&QR15%9>"MM<DE'
M368R,%I(3$9803,V,$\O5'5Q-SAZ4%!0;E!Y>F5R2EDV6&(S1VAC27I*9'IX
M>4Y36FUB-$]3>4M".6M5*T@F(WA!.W)I<DTO2RMU4C8Y-69S9%A337=I.&I$
M;4EM=D9G4W)#=3%A341V:7)Y*S$O3WIZ2DQQ96]A5DAP158Y<5!R1T13-&):
M6D)5<7I";6PF(WA!.W$W:S!!0BM%1'9U3597-G K66XU=6581VIV9&8P93-8
M5#570SA10GA&4EAI2DDU2D]$2"]!0S8T<3E8,$A7<E17=$=T3E9T86DS=30F
M(WA!.WA);V)Q<#9-<#DQ645(1EAM3W)F;3$U;S%F6#5D2#AJ-F-L,G-*64<V
M9%,U9FEA1G@X4TI';&5H8G(W9$U65E<O3E1Z:C5C4U=$>G F(WA!.V]N;WI0
M13=71GI"5# S;%5F1$<U5G!%,U!5<3(S:&ER3F9)3W8S=FU0>7):871Q1G5K
M3GA+6#)59D-X:F-O2D9"<59R5$98:E U9V8F(WA!.VMJ<G1H<55T-35C='IF
M-EA->&1B94]N<7=&:50V9D%M<G%0,E-0<#DY>G Y8D5I<&)&,6UB4T5'-#AL
M2'E2*U,R=%AL-'0W-6YH3VPF(WA!.S9,8B]!3'ED6FU#4WEG8CA!=&%O=CAZ
M1VYT-U-Z87=!5D1E4TU7;%!/5W=:=#5M.'AX6&EX-F)P:4,R,&$Q05-'1D)W
M5F=M=U!%9$8F(WA!.T@W27<V8E0X2'%L.5)A=%1Q3U!99E-X;39U<F4Q=#-U
M3&AX2$9'2W-X>DQC5C5T<BMV6$=R6%!),5,R:DHY1TQW2#AZ9C52=W-G17$F
M(WA!.WA3=6IJ:VQK5TM*4SAJ:TMI2T-76FEA04%$<51I4V]$-E$O2B]W1$Q!
M*U=R539V<6DO-VY,=5!I27%G:3-I66<X4#A!6&%N>$AT,#@F(WA!.V$V6%=A
M<FI00U!P9'1P<TA!3%!.-EAM0S54-6\O3$0O04(Y-BMO9C11.4PQ3TU8,7HQ
M9E,V5F)H5#%F<#99<7IQ97@O-7E!=F]J87DF(WA!.UA-1G!(2G,X>4YB;W="
M+WEO=WIJ-7)V:7)*=GDS+TQ31'EK:S$S8WII.#%E-EAH3$]O25)%<4=+2E@T
M:E9H57-E=3(R2W-..&Q1>%,F(WA!.V9N;')R3V=:;VID=D=32VQ7.5)6<5!!
M.%=)>%8V9#4U4D@X;#8X1T913E!U;7 W<D-X2#1J1E='+W=$3U!P2CAM6&=*
M<4)Q36](<U F(WA!.U%H3TMO83@X.&54=DQ7=EA/;BM5=DQZ86QR5$5X6%)T
M059"64Y6:T1"6EA9:'5T1G W-'%X+SA!36YZ:#5T,69Y=S%R<79L85A3-U@F
M(WA!.S%O,T8U25A)5F=4469%:3=M=$]U2W954'DP+S513%)0*UE:9C%N1EAN
M;C5#=WA.<B]M2UEO1$MG4D5E;316-4A,04@S-$0W<U9E;&8F(WA!.VU"+WEG
M*W4O.'=5+R]%1&ER1G9Y15)"-4EK64M!>EAS=DEG8FUI24XX5E-V+VY):4M-
M-E1O.'!596]T>$EI=#-#<V=*2"]#:D98<'4F(WA!.V=1>%%A1G P34MH26\W
M8495461!0D=.<U9E47HO0B]Z:U=/2'<Q:U-T3G9T865++V981E=A9FY8+W=#
M4SAV.$$O:DIB+W=$2C5C5E(F(WA!.W8U568K4SDP8B]J12]W1'ED9D970B]K
M<D9%,VYJ>DY+54)K5&UQ3U)U03 U-4%(,S1J1E=C+VTS16MN-65A=TA&47%2
M<U!9<DUH1TLF(WA!.W-B.&U88SEV*U)D,4Y%>%=32S%V+U-B=7!,>6)J-44Q
M>%9D+WIJ.7 Q=D8U5W9,.$M0<D8Q9'1'>CDO5&E294LO47IS9G!X5DYV>G0F
M(WA!.VIJ9CAV8GAM54TP8W-$25-+;%0V<7)59E%X1TMO+SA!2VHO>5AU:F8X
M66XO04]4<C1Q>4A5.4]3+W1J15I(9VM'.$YX15-R;S-I0TLF(WA!.V9337-X
M-4]%,WI95&AX0VYL6&U64$U.<F1'>C%7-&QM5F0T:7IS,&)R,EI19',S96Y/
M3U%U241P<R]'1%5I:TYX8U%7,$1Z>G5)-&\F(WA!.WA6,U!11$UH;V5C95EV
M34TR<3-&1G%L;D=F,U58:68U;3DO,5E744-4-'!826I/=U)!5UII07%G5DI*
M-D%$1E@P3"M52#54+T%+15(F(WA!.TYE,7E)2%8U1G)A,G)#=C%:5"LP,R]&
M<$@O02]03E!R3EAX96U03#<S86%B5#A/-35V5G,Q-VU/>%8T;"]W030V9C<Q
M-C4O>&IT+RLF(WA!.TI367$Y='A6,DMV1V9),R]!2E!$>D0X<G8O:S9M2W94
M4$\S+T%#:&UV+SA!8D]U+RM41#1Q=VXX9U$U.&M8-%$X6$]O4VA7.$0Y6&@F
M(WA!.V]C5EEJ*U4S;5A34$M'=#9X62M:46)+.&Q+4B]76%)N-$Y%>F,T,C1H
M;4A)<T17;$14-5EQ;5@U<R]M4&]E=F%+9$4P3&YF;FUT>&0F(WA!.UA3;S9X
M>'!&=G1Y04HS3S5P45EQ>B\X04MI-VEU=GDO,&1O>40V8U11=4(R84XR53$K
M-G5+<T<O25 X030W6&U8-7AF.&Y*8U9E:B\F(WA!.T%*9V8X;U!R=B]-1E O
M>$$T<7AJ.&AF*U5'9B]!2FI*=BM)<&EQ5B\X-40O05!(13!N+VU*9CA!-4XT
M<3E/,&(O:FHR4"]-4$8O>$$F(WA!.UEQ.&5U=CA!,6]T9BM-:V8O9%!81E=A
M9FY8+S5,>2\O04]-;'8O>6581E5B*U9(+T%*3#-2=CA!:D4O+T%#9&9&5T,O
M:W O>6UF;6HF(WA!.S5T+WEF8D979&9M=B]W0U,Y,6XO04EX2B]W06Y5>%9*
M9GEU,#)052]Y;%A46D1X4SA3.&=:=710560Q<CE&831Q>$PX<F9/9'0U374F
M(WA!.SE3.'-E6G56:T)/6D5L2W-Y<$QX0T]'-&=N:39Q<%9G2V9F:7%.+TXS
M.'EV3'5Q95@U3D0P96(V.4Q--E!C5&]R0T].23)$9F%)2$DF(WA!.VQG0G1T
M:7)/=GEO+SAL-V\S+T=*+W=$:S8K2W-S>%91=F10<W(V3#!R=4)*-#8Q0W5!
M84AX2&AK-%1L13)$5$=50DE54F)W8C@T+WDF(WA!.S,Q:E0S9E=.36ML=71#
M*S-.83%,1S%0:E0Y<5 O2S9J=C0U='1*<7A0,'DK<C<S5S9J4SA/.&54>4Q-
M.7<S67$Y+SA!>6<O2U0Y1T,F(WA!.TAZ1G(X6"LU16=063)49C=O0C934T0O
M9FYG4#)F.6)P<4Y:<2M,,'@U3WHP,FTT9E9,;3EE>EA/83=&6%EQ;&5J958O
M3"MI3DLR:S(F(WA!.TU6;3 T551'254U0F$P<CAQ-'%M;4MU>%9,8EAY,6].
M<'%S,G)7,6Q&1G%.>'DY83959D<S36=T52LU1TMO-C9T<F4V='!R5S114S(F
M(WA!.S@V3D9.1S-2:V-C5U4O34A&54QO*V@V4F\Q<S%R<&1Q;'!B=35L84]-
M54)C9TM7*S52:7%",3-Y4C55,3914S9T<'-6>D]">#EF-&\F(WA!.S5+1&]#
M.%I2:4(X.%969$PX;V579$QT2C=3=S R0T,S=59-9'EO6&M:14E)2W5Z5EIH
M=C!*>%9(85IP;&AP9&I$65=%2S(Y<&)R>&DF(WA!.VA4;T(Q-S%*2D\U2GA6
M1&%2-6$P2%(U6C5D37-O<E-3-7 V-U)I:&5H2D9F*T-/2V\R.',W83AT6F)3
M-FI%,71/<&IM:6)O>7-+14@F(WA!.T954'!/:396;SEQ8E143%I,4S),1GI&
M1TM,>6%G2B]$1E9M<RM8=$8Q<4M/3%9B3T\X:FE9=$=S;W%&66EL4FEQ3VEJ
M:FEJ4TM.47,F(WA!.V%!2VEJ;T%"441&571B>78U9F)79C R,6I%9%=Q1#EC
M<"LX<44Y36(O=T-P=&EQ2S%44W1/,5=Z97DQ1S-3-71:0T,X36=Q<$MM;RLF
M(WA!.S1J1E8R;C9F6F%D6GA75FI#='9A=V=I2T9.;%5%:S=F4V-6475L*U=T
M0C!Q-6YU=$]S;W)A-'5V.39*27A1=G9Y,RMK-'%I=%$P*WDF(WA!.S%'>FQS
M<C9&8FDQ;4%%<TPW<7="0C,K:UEQ<S!Z4SE/,'%Y5WHP*S-7,G1)*U)31TUF
M0T-X-4=G.7EC5F5C3C5U+TMZ>F9E,T9T-6HF(WA!.W,T-TLX=%I(:&AK=F%W
M3SAA:V=(,6Q+1D0O:TTR,DMS6B]-8E90259P;V<X="M464E*<G4K;6HK<WDR
M9TUT55)U4THV=GA.27I04VDF(WA!.V=N.5=+=EAF2D=J>C9.-50P=E1:>%,T
M=#1&17DQ<E-2<74T<C=->$=+<#-I<G-6861%9$=2,41)=TE:4TMG9S=%14A&
M6&AV;GHX:$PF(WA!.S$Y464K.'%#33(P>$Q3861)+W!M3FHO=G!M*T5O9D%K
M52]6=&-'=D964#5U=GIA3WIC53,O3$@X;$1O,3)U<V5:0D909E)%3EHR84@F
M(WA!.VY(17<O=T(R3V%56G@K>4)S3W98<%AQ9&)X1&AJ>5HT3DQW;35C,W)M
M835Z6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%DF(WA!.W$W1EA9
M<3=&6%EQ-T9867$W1EA9<3=&6%EQ>#=8+WDO.&]A+TU:.50P-D]3-5!7-%%T
M1DEA9GI.1U9,9C=+=4MR3D$O3')Y8F].=TPF(WA!.W)49$]23'!F<S-%:E!+
M-B\V<&M,8V8X05DP>%9K;4MV+SEK/3PO>&UP1TEM9SII;6%G93X*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @
M(" @(" @/"]X;7 Z5&AU;6)N86EL<SX*(" @(" @(" @/'AM<$U-.DEN<W1A
M;F-E240^>&UP+FEI9#IC.#(R,#5F8BTU9C,W+30W.3,M.#5B-RTT.&4P8F(S
M8S,S-6(\+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @(#QX;7!-33I$;V-U
M;65N=$E$/GAM<"YD:60Z8S@R,C U9F(M-68S-RTT-SDS+3@U8C<M-#AE,&)B
M,V,S,S5B/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ3W)I
M9VEN86Q$;V-U;65N=$E$/G5U:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP
M1#,Q-3 X0S@\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @
M/'AM<$U-.E)E;F1I=&EO;D-L87-S/G!R;V]F.G!D9CPO>&UP34TZ4F5N9&ET
M:6]N0VQA<W,^"B @(" @(" @(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=%)E9CII;G-T86YC
M94E$/G5U:60Z,&,Y-S(V,V8M.&$W.2UA-#0S+6%C.#<M,S4T9#8Y-C P93<V
M/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE
M;G1)1#YX;7 N9&ED.F(Q938S-&(Q+3<S8S$M-#0Y9BUB9&8U+6$V8S-B-3-E
M-6)D.#PO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R
M:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y
M,$0S,34P.$,X/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @
M(" @(#QS=%)E9CIR96YD:71I;VY#;&%S<SYP<F]O9CIP9&8\+W-T4F5F.G)E
M;F1I=&EO;D-L87-S/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@
M(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI397$^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S
M=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC
M94E$/GAM<"YI:60Z83%F968V.#DM-&0Y8RTT9F8Q+6%C-68M.3DQ960P-S1B
M,&8Y/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z=VAE;CXR,#$X+3$Q+3 Y5#$P.C$V.C,W*S Q.C P/"]S=$5V=#IW:&5N
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B
M92!);&QU<W1R871O<B!#0R R,BXP("A-86-I;G1O<V@I/"]S=$5V=#IS;V9T
M=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO
M/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^
M>&UP+FEI9#IC.#(R,#5F8BTU9C,W+30W.3,M.#5B-RTT.&4P8F(S8S,S-6(\
M+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW
M:&5N/C(P,3DM,#$M,#E4,30Z-#@Z,S8K,#$Z,# \+W-T179T.G=H96X^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E($EL
M;'5S=')A=&]R($-#(#(R+C @*$UA8VEN=&]S:"D\+W-T179T.G-O9G1W87)E
M06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T
M179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @
M(" @(" @/&EL;'5S=')A=&]R.E-T87)T=7!0<F]F:6QE/E!R:6YT/"]I;&QU
M<W1R871O<CI3=&%R='5P4')O9FEL93X*(" @(" @(" @/'!D9CI0<F]D=6-E
M<CY!9&]B92!01$8@;&EB<F%R>2 Q-2XP,#PO<&1F.E!R;V1U8V5R/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^
M_^X #D%D;V)E &3      ?_; (0  0$! 0$! 0$! 0(! 0$" @(! 0(" @("
M @(" @," P,# P(# P0$! 0$ P4%!04%!0<'!P<'" @(" @(" @(" $! 0$"
M @(% P,%!P4$!0<(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(_\  $0@"00E: P$1  (1 0,1 ?_$ .4  0 #  (#
M 0$!           ("0H'"P0%!@,! @$! 0$  04!              $"" ,$
M!08'"1   0,# P, !04)"P8(!PL-  $" P0%!A$'""$2"3$B$W8X012TMCE1
M83(5=;6&&0IQ0B,SU)75%I976(%#TR07=U)B<C24)58:D:&BTG0U-['!T8*2
MLE-C@T15)C9SDZ-D1:;F&">G:!$!  (  P4$!P4&! 8" P$   $"$0,$(3%!
M!0=181(&<8&1P2)"4J$R8A,C\+%RPA0(T>&BLH*2TD,D%?$TXE-S,__:  P#
M 0 "$0,1 #\ W\                                    >ER/),=P^Q
M77*,MO\ 18MC-BA?4WO(KC504-#1T\::NEGJ*ES(XV-^5SG(B'6T^FS,Z\4R
MXFUIV1$1C,^B(=#4ZK+R<N<S,M%:UVS,SA$1WS.R%!/+#]H8XT;0UERQ3CKC
M%5R.RNC5T<F3MF=9L4AE1>Q>RJFBDJ*KL5%_BH$C<FG;*J+JGWCRK_;_ ,RU
M<1?5VC(I/#[U_9NCUSC'&''OS=_<;RO1VG+T=9S[QQ^[3VX8SZHPGA*AC>?S
MI^0_=R:LAL^YM!LQ8:I5TL6(VBEI'-;^]TKKE\^K45$]*LG:BK\GH1/NO)NA
M_E_21$VRYS;=MYF?LC"OV/@'.^O?F363,5S(RJSPI6(^V<;?:@%E?+OE;G50
M^IS/DOGV42O?[1$KLOR"I8QVKM.QDM6K6(G>Y&HU$1$5431#WW2^4N59$89>
M1EU]%*Q[GSS5^<>;ZB<<S49MO3>T^]\I3\@=^:2>"JI=[<NIJFF>V2FJ8\DO
M+)(Y&.1S7-<VI145%35%0[JW(-!,83E4P_AK_@[2OF+F$3C&=F8_Q6_Q23VV
M\GOD!VHDIWXERQS&IBI5;["@O=R7)Z5K6::,2#)6U\:-Z?@HW0]<YETSY!JH
M_4T]/^&/#/MK@]FY9U3\Q:.?T]3F;/JGQQ[+8PMWXZ?M).[^.U%!9^3^SMKW
M(LB.:RJS'%W.LEZCCU3ND?1U3YJ2H>G71K'4Z>CK\J_)?,/]N>DS(FVBS9I;
MLM\5?;&$Q_J?8_+7]S6LRYBNNRHS*_53X;>R<8G_ $M)O%#GSQ9YHV=]=L7N
M93W7(*./VE\VZN#?Q;DEO:B-5SI:"H7N?&WN1%F@62+7HCU75#CEYJ\A\TY-
M?#4Y<Q6=UHVUGU^Z<)[G)KRCU!Y3SRF.ES(FT;ZSLM'IB>'?&,=Z9!Z>]U
M
M
M
M
M
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M-JZ3F<Q%YV5S-T3W6X1/XMT\<-\Z>CC.Y3
M
M
M
M
M
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MN8T3$QC#]"*
M
M
M
M
M                                           $6N7W+[9WA5L[>-X-
MX+Q["D@[J?%,4IW,6Z7^Z*Q7Q45%$]4[GNTU>]?5C;JYRHB'L_E+REK.=:R-
M/IXV\9X5CMG]L9G9#U3SEYRT7(]%.HU$[-T1&^T]D?MA$;9=>CS#Y?[N<U]Y
M[[O%NS=7/DJ7208=B$4CG6W'K0DKGPT-&Q4:G:Q%U?(J(Z1^KW=5/T!\H>4=
M)R71QI\B/3/&T\9G_#A&R'YS><_.6LYYKK:G43_#7A6O"(]\\9VRBN>T/4P
M          :2_$!YDW;'LL'%[EAD<M3LYK'2;7;JU3GS2XHJJC(Z"O=ZSG6W
MKI%)U6F_!7^!T]CQSZN='_ZWQ:W0U_6WVI'S]\?B[8^;^+?R:Z-=:OZ#PZ'7
MV_1W4O/R=T_A[)^7^'[NRBDJZ2X4E+7T%5'6T-;&R:BK87MDBFBD:CV/8]BJ
MCFN145%1=%0X>WI-9PG9,.:E+Q:(F)QB7D&6@
M
M
M
M
M
M      "-_*OE7L_PYV?OV\V\U^2V6*V)[&R62'L?<[W<WL<Z&@H(7.;[2:3M
M7Y4:QJ*]ZM8USD]C\K>5M9SC61I]/&-IWSPK'&9GA$?;NC:]9\V^;=%R716U
M.IMA6-T<;3PB(XS/V;YPB'7N\X^;6['.S>JX[L;E3):[11-?1[=;>T\KY+?C
MUI]HKVP1=R-]I,]='5$ZM1TC_D:QK&,Y^^2?)>DY'HHR,G;,[;6XVGM]'9'"
M._&9_.GSYYYU?/\ 73J,[96-E:QNK'9'?VSQGNPB(;'N#TL
M!H;\1OF1N7&M^.<:^3-RGOFP-3/'383N#*^2:LPE)55J12M[7NGMO<J>JB]T
M":JSN9HQ./W5CH_7F7BUFCC#4;[5X7_PM_NXX3M<C>CW6FW+/#HM;,SI\<*V
MXY?=WU^VO#&-C:E;+G;;W;;?>;-<(+O9[O!%56JZTLL=1355-41I+%+%+$KF
MO8]KD<US55%1=4Z'#/-RK4M-;1A,;)B=\2YOY6;6]8M68FLQC$QNF.V'G&'4
M
M
M
M
M
M                            X,Y(<B]K.*FS^6;V[PWY+)A^*1:I"SV;
MJVY5LB*D%#11/<SVM3.Y.UC-43TN<K6-<Y/.>7?+VJYKJZZ;3QC>WLB.,SV1
M'[;7@?,WF72<IT5M5J+84K[9GA$1QF>'V[,77P\^.?&[O/C=V?/,\G=8<&L+
MIX-K=K8)W24%AH)')JJKHU)JN9&M6HJ%:BO5$1$;&UC&\_/(GD32<ATGY65M
MO/WK<;3[HCA'#TXR_.KJ#U!UGF'6?FYOPY=?N4X5CWS/&>/=$1$05/>'H0
M              OL\2WF"R/B?=K#L#R#N]1DG&.Y3>PL=Z>U]37X/-42=WM8
M>U'22V]7.59J=-5CU62)->Z.3X3U6Z1Y?-:3JM+$5U,;XW1?T]ENR>.Z>$QR
M!Z0=9<WE%ZZ35S-M+.Z=\Y??';7MCAOCC$[>K'?++D]EM.28W=J:_P"/W^F@
MK+'?*.>.II*RDJ8TFBFAEA5S'QO8Y'-<U51475#A5GY%\J\TO$Q:)PF)V3$Q
MPESJR,^F;2+TF+5M&,3&V)B=TQ/8]J=)U0
M
M
M
M
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MGS;9>;6:WK.$Q.R8ESQT6MR=3DUS<JT6I:,8F-L3'<^E.V=T
M
M
M
M
M
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MQ6>6',>"N2-VWW'^>YQQAR>I62[8W$[VU=C59,[5]PM;97-16N7K44VJ-?\
MAM5'Z]_Q[JCTJR>>9?YV3A34UC9/"T=EO=/#=NW?:NDW5W.Y!F_DYV-]+:=L
M<:S]5??''?&W?NUV]W"PG=?"<9W'VXR:DS+!LRI(Z[&LEH9$EIJNFE3HYJ]%
M145%:]CD1S7(K7(CD5$X.<PY?GZ3/MDYU9K>LX3$[XG]O:Y\\NYCD:O(KG9-
MHOEWC&)C=,?M['V1V;O0
M
M
M
M
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MQ,?MO[8WQ.R7WQV#R
M
M
M
M
M                                    ?,YIFF)[=8GD.=YWD-)B>'8G
M235V29)73,IZ2CI*=BODEED>J(B(B?Y?0G4[G1Z/-U&;7*RJS:]IPB(WS+M=
M;K<G39-LW-M%:5C&9G9$1#!'Y3O*=FW/'-I,+PN2KPWC)AM6Y^'8<]RQ5-\J
M8E5C;K=6L546145?8PZJV%J_*]7.7G;TOZ7Y'(LC\S,PMJ;1MGA6/IKW=L\?
M1A#\_.K'5C/\P9_Y65C32TGX:\;3]5N_LCAZ<95#'UI\<
M          !:%XU/)QNAP%W!@HIYJO-N/.4U37;C;5^VU]DZ3MC=<K6DSD9#
M6QM:FJ:HR9J=C]%1DD?S+J1TTTO/M/C&%-16/AO_ "V[:_;&^.,3]4Z8=4M5
MY>U.$XWTUI^*G\U>RT>R=T\)C?7LYO+MGO\ [<8QNSM#EU+FN!Y=3MGL][I7
MZIU3UX9HW:/AGB=ZLL4B(]CD5KD14.!_..3ZG0:FV1GUFF96=L3^^.V)X3&R
M7Z$<EYUI>8Z:NHT]HOEVC9,?NGLF.,3MAR<>,>4
M
M
M
M
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M'N<T'AGFP
M
M
M
M
M                      /57R^67&++=LDR2[4U@Q^P4T]9?+Y63QTU)1TE
M-&LTLTTLRM8R-C&JYSG*B(B:J=7(R+YMXI2)FTSA$1MF9GA#I9^?3*I-[S%:
MUC&9G9$1&^9GL8:O+YY8KES(R2HV0V.NE79N,6)52_/*Q%DIILVN%/(BLK*F
M-4:]M%$YNM+ _JJZ2R(C^QL7-SI)TJKR?+_J=3$3J;1Z?!'9'XIXSZHV8S/
M[K)U=MSK-_I=+,QI:SZ/S)CC/X8^6/7.W"(HN/M[X*
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M=FQ>P?#GWP
M
M
M
M
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M6FUIWS,XS/KE]TTNDRLC+BF76*UC=$1$1'HB'O3H.X
M
M
M
M
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M7MMF9G&9],RYCZ31Y6GRHR\JL5I6,(B(PB([HA]"=N[D
M
M
M
M
M
M_CG-8USG.1K6HJN<JZ(B)UU74#'5YG?+U)NE5Y#Q*XKY=_\ XMIO:T6\FZ%O
MD5/ZR3M<L<MKH)XW=;<W32>5O_.%U:U5A15FY>]'.DG]+%==K:_J[Z5GY?Q3
M'U=D?+O^]NX8=;.L?]7-N7Z"WZ6Z]X^;\-9^GMGYMWW?O9FCDFXO
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M)XUF)C[./=O?3'8/)@
M
M
M
M
M                   &1WS/^7^FRF')^'_%/*5DQ_OEH=[MW[=4:,N*-[HI
MK-;)H5]:GU]6JG:NDFBQL58^]7\L>CG2.<J:Z_75^+?2D\.RUH[?ICAOG;AA
MP]ZV]98S8MR[06^'=F7CCVTK/9]4\=T;,<<LQR?<40
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MWG\,SNG\,^J9W180?%7((
M
M
M
M
M                    #*MYG?,$VV-S7AMQ9OR.N;DJK1OONS2NU2E1>ZFJ
MK+;)$_SOX4=7.GX'6-GK]SF<H^CG2/Q>#F&MC9LG+I/'C%K=W&L<=\[-_$SK
M9UE\'CY;H;;=M<R\<.$TKW\+3PW1MQPR6G*UQ"
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M '&5R]
M
M
M
M
M   #,?YG?+[/M@[(N(W%?)VMW#GBDI-Y=VK?.BNQYK^Z.6TVZ6)?5KU3I43-
M7_5T7L:OMNY8>2W1SI)&I\.OUM?T]]*3\WXK?A[(^;?/P[^+?6SK).D\7+]!
M;]3=>\?+^&OXNV?EW1\7W<>KG.<Y7.57.<NKG+U554Y=.&;^
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MS\O?/XNR/E].[@WURZVSKIMR[06_1C9>\?/VUK^#MGYOX?O54G(EQ6
M        7'<)>>$B26;9S>^[-6%6QTN%;A5+U1R.1>R.EN$CUT5%31L<R^CH
MC]=>Y.+_ %8Z/QA;6Z"NW?>D?;-8_?7V=CF+T3Z[3C3E_,K;-D4S)^RMY^R+
M>JW:N6.+CF0
M
M
M
M
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MC*BO+^97^&-E,R>'96T]GTVX;IV83%T**CD1475%ZHJ>A4.*[F=$OZ
M
M
M
M
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ME'W=?K:]]*3_ +K1_MCU]CAUUVZUQA;EO+[]V9>/MI6?]TQZ(XJ;#E$X;@
M                MMX-\Y%QM;1LQO/=]<<7LIL'SBI?UMZ]&1T=9(]?^;_)
M'(O\7^"[U-%9QLZM])/S_%KM#7X]]Z1\W;:L?5VQQWQMW\M.A_7#^F\/+N8V
M_3W4O/R]E;3]/9/R[I^'[MVR*CD1475%ZHJ>A4.)[FS$OZ
M
M
M
M
M                                    41^7GRV6WAY9:_838RMAO')S
M):-KKA=E8R>DPJ@JX^Z.JF:]%9)72,7NIX%14:FDLB=O8R7[ETEZ46YO>-5J
M8PTU9W<;S'".RL<9]4<9CX%UCZP5Y+2=)I9QU5HVSPI$\9[;3PCUSLPB<.%W
MNUTO]UN=]OEQGO%[O51-5WB[U4KYZFJJJF1TTLTLDJJY[WO<KG.<JJJKJIS:
MRLJN72*UC"L1A$1NB(X."&=G7S+S>TS-IG&9G?,SOF7KSJ.F
M            %S_B=\4^5\WLQHMTMSZ*IQGBWA]:W\=714D@J<LJZ:1%?;+>
M].UR1:IVU52U?435C%]IJK/CG57JEE<DR9R,F8MJK1LCA2)^:>_LCCOG9O\
MMO2+I+G<]SHS\^)KI*3MGC>8^6O=]4\-T;=V[_&,8QS"L<L>(8A8Z7&<6QFE
M@H<>QZA@CIJ.BHZ:-(HH88HD:UC&-:B(B)HB'!G4ZG,SLR<S,F;6M.,S.V9F
M>,N?>ETN5D949>7$5I6,(B-D1$;HB'O3H.X   "HWG5S>BL<-ZV2V>NOM+[,
MCZ7/,UII%TH&KZDE%221KUG7JV61%_@^K4]?56<E>D/2:<V:Z_6U^#?2D\>R
MUH[.R..^=F_B1USZW1D1?EO+[?J3LS+Q\O;6L_5PM/R[H^+'PTFG*YPI
M                 6O<)N=E1B$EFV@WHNOML.5&4N(9O.Y5DM2Z]L=/5O<O
MK4WH:R1>L7H7^#ZLXY=5^D%=3%M;H:_J[[4CYNV:_B[8^;AMW\K>BG72VCFO
M+^8VQR=U+S\G96T_3V3\O'X?NWB,>R5C)(WI)'(B.CD:J*US535%14]**<2I
MB8G"7-^MHF,8?Z(H
M
M
M
M
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MCY/PU_'VS\O\7W:+7.<]SGO<KWO55<Y5U557JJJJG+N(P<&IG%_"H
M               6I\(><JX%^+=H=Y+LY^#^K#B&93N5SK.OH;35+EU5:7Y&
M/_S7H7^#_ X[]6>D?]9CK=%7];?:L?-WQ^+MCYO3OY3]$>N/]!X=!S"WZ&ZE
MY^3\-OP=D_+_  _=O,@GAJ88:FFF;44]0UKX)V.1['L>G<US7-U145%U14.(
MUZ36<)V3#G)2];5B8G&)?J9:
M
M
M
M
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M.=JJJJKJJJ<Q:4BL81LB' V][6M,S.,R_(TP
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ME!@DK:KQ:;[0P7.QW2FO-MJ41U-<:2>*H@D:J(J*V2%SFJFBZ]%"/8@
M        XJWSW5M^QNSNY>\5UM4U]MNVEEK[S76:G>R.>IBH('3NCC=)ZJ.<
MC=$5>@%&?_>']F?\.V3_ ,ZVK_S28M>$_P"\/[,_X=LG_G6U?^:,3PG_ 'A_
M9G_#MD_\ZVK_ ,T8GA/^\/[,_P"';)_YUM7_ )HQ/"MWX;<JL?YD[*4.]>,X
MI689:ZZXW"W,LE=-!45#7V^1L;GJ^GT;H[NZ(5E*H
M
M
M
M                      51^3_R?X!P%P!;'8UI<TY'YI2O=M[MZYZOAH(7
MJZ)+K=4B<CF4K'(OLX]4?.]%:U4:CWL^I],NF6HY]J/%;&NFK/Q6[?PU[^V=
MT1MGA$_).JG533^7M/X:X7U-X^&O9^*W=V1OM.R.,Q@2W#W#S7=C.,HW(W&R
M2JR_.,SK):[)<CK972U%54RKU557T-:B(UC4T:UJ(UJ(U$0YX\OY?DZ3(KDY
M-8K2L81$<(?GOS+F.?K,^V=G6FV9><9F=\S^WL?&G>.R
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M/X=UZ9Q$<Y@                   ,/_FM^T+W6_)F+?5VD)+=54(4
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M*$
M
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M6KI9VH]DD;V*J*BHO^3T+U*R^B
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M,-]L[@J&[5;<.>OLU6/^#=<KBL2HZ.BA<NFB*CIGI[-BIH]\?TOIMTYU'/\
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M9[BY%^;I L.OD(V   &UGP9_ 5C_ +SY)])C*Q*X4(
M
M                                                 1[Y6;]VGC#Q
MYW5WSNT$=:F!6Q\UGM<KG-CK;K4R,HJ"F<K/61LU5-&QRIU1%5?D"Q#KV-Q-
MP<PW7SG*MR,_ODV1YEFE;/<,AO,[E<^:HG?W+HGH:QJ:-8QNC6-1&M1$1$(V
M^,   -$_@=Y@W?'=Q+KP_P QNKZK$<ZBK;MM/'*Y7_B^]T<+JRMI(NY?5BJJ
M>.2;M]"21JJ)K(Y5,S#5N5D
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MM=/IZ^'+KNCWSVS/&7YW<^Y]JN9ZJVIU-IMF6G;/NCLB.$.)3RKQ
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MJY>76*TK&$1&Z(?G?K]?G:K.MG9UIM>TXS,[9F9>I.Y=H
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MW*SW%R+\W2!8=?(1L   -K/@S^ K'_>?)/I,96)7"A
M
M                                                 "C7S^9-4VCA
MO@]AI)G1?UMSZTPW%B([LDI*2RW6M5KE1437VT<3D1=?1]XDM58ZPT   $H^
M$.45&&<Q>+N14\KH4I,]Q6*M<S57K25=YIZ.I:B(K=5=#*]NFNG7KT!+L.RN
MF
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MKGFJJJ9]34U+W25%1(Y7R22/57.<YSE55557554Z[RL1@_(*         /\
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M70+B@->+->,>N=;9;_:JFQWFW/6.X6FL@EIJJ"1$U5LD4S6O:[KZ%0*]8
M  $D^*O*G=7B#NQ:-UMK+JL51 K8,HQB9S_Q=?+8KT=+1U<;?2UVFK'IZS':
M.:J*@);RN,7)3;;EAL]C.\FV%>LUGO;?97>S3*U*VT7.)K5J*&J:WT2Q*Y.J
M='-5KVJK7(JUTY2!     "'GD&^![E9[BY%^;I L.OD(V   &UGP9_ 5C_O/
MDGTF,K$KA0@
M
M                 !4!YP]L;KN)P3O=YM,+JF3:7)+)D]=3,1SGNI&,JK#,
MY$;\D;;HLCON-:J_(%AB@(V   $\/&3MC==U>=G&RS6R%SX\7R2BR>ZU*([L
M@I,6?^/G.>J>A'.I6QIKZ7.1/E"2WW%8
M                                       !E7\AU=5\/_+ULSRKNU(]
M,(S=<>NMUN;&ND1:6AHF8=>(F-];66&BC9)VM33UV_*JD:C<MF\P%?177QH[
M_P!TME7'7VVY0X9/;Z^%[9(9X)LYL<D<C'L54<US5145.BH5(0A\.O&;8+?S
M@5F-MW;VEL.:37W+,@MU3?ZNV4;[O#3?BZW=GS>O]G\XA=&YZNC=&]%:[JG4
M$[U>GCQW)RC@;Y)\@XXY3>YXL%RS(Z_ <KIIG21TU35)6OI['<TB_!1SYO9(
MV1432*=_712-2M$\^6^MGQ/CAANPM'5QSYAN_>Z:NK+6B]TD5CL3EJ7RJC>K
M5?5K R/7\)$?I^"NB4JK\_4Y[B?]E*C_ -@?]9OP4_\ :A_^"_\ Z;[_ */O
MA<6NHK     (6\YN<VS_  0V?J]R]RZM+ID5T2:GVUVUIYF,N>17-C$=[*+N
M1WLX(^YKJBH<U6QM5.CGN8Q_N?DCR1J^>ZN,G)C"L;;6G=6/?,\(X^C&8](\
M^>?-%R#13GY\XVG96L;[3[HCC/#OF8B>O:Y1<G-UN7>\N4[V[OWE;EDF1/[+
M?:XG2I;[/;HW.6GH*&*5[_94\*.71NJJYRN>Y5>YSEY^^6/+6EY3HZZ;3QA6
MO'C,\9GMF?\ *-D/SH\U>:=7SG6VU6HG&UMT<*QPK$<(C_.=LRCV>P/70
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M,(B/V]L[YG;+\WN;\WU.OU-M1J+3?,O.,S/'_+A$1LB-D;'SAWSQH
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MZKY44\PZB(^J)]M8E^E'13.MF>5M+,_3,>RTQ'V0E,?/7U(
M    ,/\ YK?M"]UOR9BWU=I"2W55"%  '.O%WXF..WOUB/U@I 2[&DKI@
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MDGTF,K$KA0@
M
M                 !Z#*L7L.;XQD6&Y5;([UC.64-7;<AM$R:Q55%70.IIX
MGI_P7L>J+^Z!@^Y^\"-R.$NZ%QM];;JJ^[-9#52NVOW*]GW4]33OUE91U3XT
M[8JV%NK7L=V]_:KV)VKTC<2@"% /8VBSW;(+I;['8;747N]W>:.GM-GHX):F
MJJJB9R,CBBBA:Y[WN<J(UK4557T ;.?$;X[KGQ$P>[[J[M4D<6^^Z-)#!4V9
MJLD_JW8^YE2V@5[=4=4S2-;)4JU5:BM8QOX+G.K$RN4"
M                                                    @GY!N$^.
M<W]C:G!)JJ&P;C8M*^Y;4YA,URQT5R]G[-\%0L:*_P":U3$1DJ-1514;(B.5
MB-4L2H@X_<XLDXCV2NX"^379&MRO:.U)#2V62X4$-TEH+=!5,GIHW0SK[*Y6
MR*6)LE/+"]SHT;VL[T:QC(N"ZK9#FOXQL(P2DLNS&]. ;885+-+518O&L>,=
MM14:+)(^BKXJ25'NT1%5S->B)\A4P07Y;>03Q5XGD=?N?C6TV,\H>1+)::IM
ME[H[!"V)MPH&L2DGK;U74S6N;%[%B-="DS]&HFB)U2+A+C#@[PRW]YG\A:;G
M[SFHYZ.S4E33U^UNW%?324WS_P":/6:@[**=5=36JD<J/A8]%=4.]=W<USGR
M"9:6"L@    B7S/YD[2\'ME;QO%NI5NJ51RT>$X53/8VXY!>'QN?%1TZ/U1J
M:-5TLJIVQL17+JNC7>U^3?)^KYWK8T^1'?:T[JQVS[HXR]0\[>=='R+0SJ<^
M>ZM8WVMV1[YX0Z]KE[R\W@YJ[R7K>/>"[I/75*+38KBU.KVVRP6IDCGQ4-%&
M]5[6-[E5SU]:1RJ]RJJG/[REY2T?)M'&GT\;-\SQM/;/[;(V0_.CSEYQUO/-
M;.IU$[=T1&ZL<(C]L9G;*+I[.]5                        "1_%7BKO!
MS%W@L.S.S-A6Z7VZ+[:]7J;O9;+);&/:V:OKYFM=[."/N3Y%<]RHQB.>YK5]
M=\T^:=)R?23J-1.%8W1QM/"(CC,_9OG8]E\I>4M;SK6UTVFKC:=\\*QQF9X1
M'V[HQF782\'N$^U/!792U[3;;P)=+M4JRKW#W"G@BAN.0W56JCIYO9ZJV*/5
M64\/<Y(V=-7.5SW< ?.WG35<\ULY^=LC=6O"L=D=_;/&>["(_1?R)Y&TG(-#
M&GR=L[[6XVGMGN[(X1WXS,QST][H   $6^4G*+$^-F'I6U;67K.KZR1N&XBC
MU19GM]59ZA6]64\:JG<OI<OJMZZJWZ%T]Z?:GGVJ\,?#DU^_;L[H[;3]F^>_
MY=U1ZH:3RWH_%;X\^^/@IV]\]E8X]NZ.V,U^>YYE.YN77O.,TNC[QD>03+-7
MUCNC4Z=K8XVIT9&QJ(UC4Z(B(B'.[DW)]/H--73Y%?#2D81'OGMF=\R_-OGW
M/M5S/5WU.HMXLR\XS/NCLB-T1PA\>>3>'                $4.3')&AV<M
M7]7\>='<-Q+Q$KJ&G=VOBMT+O52HG;\KE_S;%]*IJO1-%ZF7EXNMDY,WGN4R
MW2Z7&]W&NN]WK9+C=+G*^>OKYGJ^6:61W<YSG.ZJJJIW+RM:Q$80\$-
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MUGP9_ 5C_O/DGTF,K$KA0@
M
M                              ]!E&*XQF]AN>*YECM#EF,WJ-8;OCUR
MI(*ZBJHE]+)8*EKV/;]Y44"K/<GPF\"]P:ZJN5MPJ];8558Y[ZAN-WR>&#O>
MU4]2GNS+A#&B*NJ-C8UJ:>C3H%Q<76;P$<)[75)45V6;A9'"BMUH:R^61D2Z
M+JJ:V^RTK^OH7UOW-!@>)89Q_P"#O%;C Z.LV9V<MF.9"R-T;LRJ$FNE[<U_
MX:)7W-\\[&O_ 'S(W-;\FFB(#%+ (
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MEVN%]OMPENMXNLKIKA<)G=TDLCO2JK_XD1.B)T3H=R\M6L1&$/5AH
M          -)?B \R;MCV6#B]RPR.6IV<UCI-KMU:ISYI<4551D=!7N]9SK;
MUTBDZK3?@K_ Z>QXY]7.C_\ 6^+6Z&OZV^U(^?OC\7;'S?Q;^371KK5_0>'0
MZ^WZ.ZEY^3NG\/9/R_P_=V44E727"DI:^@JHZVAK8V345;"]LD4T4C4>Q['L
M54<UR*BHJ+HJ'#V])K.$[)AS4I>+1$Q.,2\@RT               8?_ #6_
M:%[K?DS%OJ[2$ENJJ$*  .=>+OQ,<=O?K$?K!2 EV-)73
M*6/,AP0HN1>SM;OQ@%G[M[MEZ"6>>.!C?:W[&J=75-31O3HKY:9%?/3Z:JOK
MQHBK(W0L2QD$;   "QKQ3\@I>/7-?:BZ554M/BFY4_\ 4[-&:Z-6DOTT<%-(
MY55$1L-:VGE<JZ^JUWW0DPWB%8   "'GD&^![E9[BY%^;I L.OD(V   &UGP
M9_ 5C_O/DGTF,K$KA0@
M
M
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M/(-\#W*SW%R+\W2!8=?(1L   -K/@S^ K'_>?)/I,96)7"A
M
M
M
M                  #AGD!O[M?QBVER_>O>'($QW!L-@22NG:WVM34SR.2*
M"EI845%EJ)Y'(R-B*G5=55&HJIYCD'(=5S/5UTVGKXKV]D=LS/"(XO">8O,.
MEY5H[:G46\.72/7/9$1QF9V0Z^3R%<_MSN?N\DF<Y2U^,[=XPDU)M3MC'.Z2
MEM% ^3N=++IHV6MJ-&K43=J:Z-:FC&-1.?G3_P A:;D.C_*I\69;;>W&9]U8
MX1Z]\R_.OJ-U#U7F'6_FYGPY==E*<*Q[[3QGU;HA 4]\?/@
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M&R-\\;3QF>^?LW1L?FEYS\XZWGFOMJM3.,SNCA6O"L=T?;.V=LN*3V-ZH
M             . =_-_,>V1Q[VTW9=<PNK'?U;QONT5ZIZOMY^WJV%J^E?2Y
M?5;\JINE,74R\N;3A"D?*\JOV;Y#=<IR:O?<KU>95EK:IWW5Z(UJ)T:QJ(C6
MM3HB(B(=T\KEY<5C"'SP=0                      TZ>"/R;UV%Y+CO!_
M?"_+/@V55"T^P.453VHMGNU3(Z5+-+(]4UIZN1R_-M=59,Y(TU;(WLXT]<NF
MM<[+MS+31\=8_4B.,1\WICCVQMX;>4O0+JE;(S:\KU5OT[3AES/RS/R^BT_=
M[)V;IV;!SB*YE@             ,/_FM^T+W6_)F+?5VD)+=54(4  <Z\7?B
M8X[>_6(_6"D!+L:2NF                ,YW[0QM+#<=LMA=\:2D1*W%;U6
MXQ>JEC55[Z:\T;KE3>T5/0R*2W2HU?1K+IZ50DM594@T   &W_PJ9L_+_']M
MG;IIO;U& W3(K)-(NO=VMN\UUB:NJK^#%7,:GHZ(G[JUB5KX0  0\\@WP/<K
M/<7(OS=(%AU\A&P   VL^#/X"L?]Y\D^DQE8E<*$  $(=_O(SPYXVR5UMW%W
MHMU5E=!W-EP:R=]]NZ3-<K5BEAMJ2MIW]%Z5#XT^_P!4"X*C]U/VA_%::2>D
MV3X[5]YC77YO?LHNU/;NW3T:T-J96]VO_I*$Q7PH.9=YZ.;>022)8+7A6"0:
M.2%*"QUE5*B+W:*YUWKZMJN3N3JC$3HG3TZL5\+A:N\S/D9JZA9J??N&UQJB
M(E)!B6%NC14^76IM,SM5_P"4# H?,SY&:2H2:HW[AND:(J+23XEA;8U5?EUI
MK3"[5/\ E P<PXEYX^<6/.A2^4V&9W$SM2?\8V&HIY'HFB*J.LU;1(CE^[VZ
M(OR:=!B>%-7:_P#:(:%\M'1[T\;Y::'5/G^0XO>63NTUZ^SM]VBB3T?=K!BG
MA6T\?O)QPOY'U%#:,+W>I<;R^O5C(,&R5BV&Y/ED_!BA6L7YO42+I^#3S2*5
M,$^P@                 ?,Y=FF';?V*KRC/,LMF$XS0)K79%=Z^EMM#"FB
MN_A*BL?'&WHBKU<!5YO%YJ^"VU<E50V/,;IO)>:57,?0XK:WSTZ2)Z/]=NKZ
M&F>Q?E=#))T^15Z!<%;VX'[1)D<TD\&U?&FAMT+%_P!6NN07Z>M=(W1>KJ6W
M4U*C%U^1)W?_  3%?"B+DWG<YU7Y9/Q5)AV%=Z.[4MF/2R]NJ-1%3\<UE?Z-
M%TUU]*Z_)HQ7PN*:[S,^1FKJ%FI]^X;7&J(B4D&)86Z-%3Y=:FTS.U7_ )0,
M'XT_F4\CD,\4LG(1E7'&Y%?2R8C@Z,D1%_!<L5G8[1?O.1?O@P<DX]YS>>ME
MD8^Y7_&,N:URJZ*XXW3Q-<BZ>JOXIDHET33Y%1>OI&)X4H,#_:'MWJ&:!-S^
M.^-Y13ZZ5+[#=+G87HBIIW-2X)=TZ>G15Z^C5/2,4\*P?:+SP<-\\EIJ#<2W
M9)LM<951):VXV]MVM37.71$;465U1/\ NJ^F:B?=&)X5L6U^]6T6]EE_K#M'
MN59-Q[.W3V]99[C2UWL'+^]F9 ]SXG?\5Z(OWBLX.3@              (@<
MTN9FV'"O:.X;A9S5,N637)D\&VVWT<J,K;]=&1ZMC;T<L=/&KFK43JU4C:OH
M<]S&.+$/'X2\T-MN;.T5)N'ABMLF46I8Z7<;;V6>.6MLEQ5JKHO;HKZ>7M5U
M/-VHCVHJ*C7M>UHF$QP@    (0\F/(EQ-XH+5VW<_<R&NS6E3_V;6-J7>_=R
MM5R-D@@<C*951-46IDB1?D7J%B%)F[W[0YEE14U='L-Q_M]IHF*Y*+(,MKZB
MOFE;KZKGT%G=2-B73TM2JD3[_P!V8KX4'<E\V_D$OKYG6O<:S86V7^+CMF+V
M65(_7[_5_'$%>OH]7UE7I]_J,5P?',\R/D>8]CG<B4E:U45T;L1P7M<B+KHO
M;9471?O*#!SC@/GDYL8M4P_UNHL1W-H-=*J.OLTMOJ5;WJ[^#ELM12,:[3U4
M5T3DT^15ZC$\+1WX].<,/.W:3(MQ5V\=MO<\0N_XEO-H_&*7.":H;0P5JS0R
M^PIG(QR3IZCFZIZ-5])69A/@(  .)]\-Z]O..NUV3[Q[JW:6QX#A_P R_'UT
MAI:FMEB_&%Q@M4&D-(R21W=-4L:O:U=$75>B*!7S^NN\>G]ZUT_LMD7\D"X'
MZZ[QZ?WK73^RV1?R0&!^NN\>G]ZUT_LMD7\D!@\N@\T'C]N==16ZDW3N<E7<
M)8X*5BXOD+4=)*](VIJM)HFJKZ08+4P@  ^=RO+\2P2Q5N49QE%NPW&K:B.N
M.176MIK=0T[571%DGK'QQL3]UR 55[U>;/A!M1/4VS&LCNN]E[IT<UT&+V]'
MT+)4]".KKK)1PO:OI[X%E3_+T"X*S]Q?VB#<BLDFBVDXYV/'8F*Y(*[([O7W
MITB?O7.@MC+6C/OM25W[I,5\*)F1><SGM>Y'26W(,8Q!JN1R0V[&Z:5J(B*G
M:GXVDK5T777TZ]$Z^G5BOA<:/\R/D>>][F\B4B:Y55L;<1P7M:BKKHG=9571
M/OJ#![2U>:#R*6][W5>]U)?6O5BMCJL3Q)C6HU5543YC;:==':]=57T=- 8.
M>L,\_',2Q/ACRS#<(SJB1R+4226RYV^L<WO551DM#<&Q-Z+IJL*^A/OZL4\*
M>NTW[0KM%>IJ:BWIV*OF!K)HR6]V&OI,@ID<JZ=[X:MEME8Q$ZJC5D=]Q%&)
MX5Q&PO,CC'R;@:[93>.T9C<^U7S8M[5]!>XFM;WN<^W7%D%4C6]=7I'V]%T5
M2I@DR$       <0[O;_;*;!61,AWFW0LNW%LD:YU'^-*Z&"HJ^Q41S::FU6:
MH<FO5L3'+]X"H7=_S[\6,.?54.TV#9)O-7P]WS>XNBBQRT3:*J)I-<$EJTUT
MU]:C3I]_H3%KPJ\\[_:$.25VFF;MWLUAN%4$G\7^,EO%]K(^NO26&IML2K\G
M6%?_ (&)X4:+WYL?(1=5G6@W0M.,^V1$C2AQ:P2>R5%UU;^,J:KZKZ%[M1BN
M#Y3]<?Y(/\1G_P#*&!_T*#!]59O-AY";6D/S[=&U9'[-KD>M;BV/Q^T55U1S
MOQ=2TO5/DTT3[J*,3PI%83^T%<H[1)%'G>U&$YG1,5O>^CAO%FK'M[E5R+*M
M;61:JFB(J0II\NHQ3PI][2_M W'7)Y*:BW>VHR3:FKG5$DN5!+2Y+;(ONK(^
M-*&I1/\ D4SE&)X5O>R/*7CSR/M[KCLEN[9=P/9-[ZJUTM3[*YT[%1%1T]!5
MMAJH477TR1-*S@Y\          /2Y)D-FQ''K]E>1US;7CV,455<;[<WM>]M
M/144#JF>56QM<Y48QBN5&HJ].B 0(_6Q>/3_ !+VS^:\B_H\+@?K8O'I_B7M
MG\UY%_1X,#];%X]/\2]L_FO(OZ/!@_VSRO\ CVD>R-O)>U(YZHC5=;<A:W55
MTZJZWHB)]]08.>=N.9'%+=RM@M>W/(;$<HO-4O;2V&&^4,=QE57JSU*2HDCG
M=U3Y&?<^Z@,$E0@          <>[K[HX;LKMUENZNX5PDM6%8/2.K<CN,5/-
M520T[7-8KFQ4[7O>NKDZ-15 KC_77>/3^]:Z?V6R+^2!<#]==X]/[UKI_9;(
MOY(# _77>/3^]:Z?V6R+^2 P/UUWCT_O6NG]ELB_D@,%I5DO-NR*RVC(+1/\
MZM-]I:>LM=5VN9[2GJHFSQN[7HBIJUR+HJ:A'M   ""N_P!Y)N&G'":OM>>[
MS4%URRWJYDV#6!'WVZMF;KK%*RW]\=._IZ*B2/\ \:!<%26ZW[0_8():BCV0
MXZU=TAU=\UR'*;M%1*B)T3NM]ICJM=?3_P [33T==>DQ7PH0Y=YY>;^0R3?B
M&APO X')(VG;;[%55,C&NU1KG.O%=6-<]NJ=>U&JJ?@Z=!BOA<,UOF8\C554
M/G@W]BML3D3MHX,2PIT;=$TU1:FTROZ^E=7 P?ZH/,UY&*.=9:C?J"ZQJU4^
M:U&)88UFJJGK:TMJA=JG_*T^\#!S)B/GEYOX])#^/J'"\\@:D;:AMPL5532/
M:W1'.:ZSUU&UKW:+U[5:BK^#IT&)X4V-L/VB&T2R4])O1QOJ:&)%3YW?\7O,
M54Y4Z:]EONT5.B:>GK5]?O>E6*>%;CQ]\E'#;DI4T5GP'>&CM.7U[FQTV"Y
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MX4]7'MGT0_//K)U(MSWF$Y>5/_C94S%>RT[IOZ^'9'?,JACZT^.
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MR,B.^UIWVGMGW1PA^:?GOSUK?,&OG4ZB>ZM8W5KV1[YWS/LCA<]J>E@
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M<[#'DR[/;7UBO9'M[C4\U,Z>G<NB,K[@G;452JG1[=61.]/LD(U$*Q0H
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MED4F6;O[C7C<6_O5WLJZZUT]6D#'N[ECIXY'>SACU]$<;6M3Y$#3C
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MSVZK&D;B%$5145%943U=7.^JJJI[I*FID<Y\DDCW*YSG.<JJKE5=55?2%?B
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M^.#67<G:?,*+.,*O[.ZW7RBD[V=R(G?%*QR(^*:-5TDBD:U[%Z.1%*RY%
M     X*Y1?#-R*]Q,N^K]6!URQ'4    !9#Q(\I7*;B?<+9;:3+)MT]K*56,
MK-K<BJ9JJF93M1&]M!5R>TGHG-;KV)&JQ(O5T3_0$F&Q#B+S'V;YG;<-S[:F
MZNCKK8L4&:X/6=C+K8ZV2/O2*HC:JHZ-^B^RF9JQZ(NB]S7-;69A*T(
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MJC_9GO3'#WW+:FZ5,;I*ES&JZ1]JJE2-M;&U&JY41K96HBJZ-&IW+69A9.$
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MR\B(MZ;?+'[[?\+X7U^\XVY9R;\G+G#-U$S6.V*_//LF*_\ $P>'.=P#
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MO6XVG_#LCAZ<9G\V.H/4'7>8M=.?GSA6-E*1NK'9';,\9WS/9$1$<#GN#T0
M               <0[S[R8SLQB<]_O<J5-UJDDCQO'FN1)ZZI:W5$3T]L;=4
M62331J?=<K6KNE,6JUFTX0HYS_/\GW,R>ORS+*]:ZYURZ,8FK8::%JJK(86*
MJ]D;->B?NJJJJJJ]S$8/+965%(PA\85U0                         :
MOV=OD+5[<<P,BV*KZU6XQR&L52RDH5<B,3(,:AEN]++ZW_[HE8Q43357-^XB
M'P3^X/R_&HY174Q'Q9-H_P"6VR?M\,N0_P#;?YCG3<YMI9GX,^L_\U<;1]GB
MCV-O)PJ<Z0            ,/_FM^T+W6_)F+?5VD)+=54(4  <Z\7?B8X[>_
M6(_6"D!+L:2NF                *[O+%]GIR7_ "9:_K%;PL,&1&P   UB
M?L\3*I-D.0<CV2)1ORJWM@D5'>R65MH:LB-5>G<B.9W:==%37Y!#-FAHK(
MAYY!O@>Y6>XN1?FZ0+#KY"-@  !M9\&?P%8_[SY)])C*Q+AWR:^7BU;!2W_8
M7C774^0[UP^TI,RSW2.IMV*2:(UT,+7(YE17MU5'-76.%W1Z.>CF-BQ#)+D^
M49'FN07C+,OOM7DV3Y!/)57R_P!=/+55=742KJZ26697.<Y?NJH:>B
M     '+6R&^6Z''3<>Q;K;0Y3-B69V!7)!6QHV2&HIY-$EIJF&1%9-!(B:/C
M>BIZ%31R(J!NLX*<V< YO[/P9YC<+<?S6P.BH]S< =*DDUIN+F*Y',<NBR4T
MZ-5T$FB:HBM71[7(E8F$V @          5-^0KRJ;8<-J6NV^PN*EW.Y"U$*
M+!B#9];=8?;,[HY[O) O<UVBH]M*U4D>U455C:YKU+$,=F^W(3>+DKG59N+O
M3G-9FV2U**RD=.Y&4E!3]W<E/1TT2-BIX47KV1M1%75RZN556-N&
M      2+XS\J=Z>)6X-+N)LUE4EFK56-M_QV;OFM%YI6.[OF]?2HYJ2L75='
M(J/9KJQS7=0-N7!KG=M5SAVY?DN(.3&L_P =;%'N+MC43LDK;7.]-&RQN1&^
MWI)51?93(U->K7(UR*TK$PG"$        .!N2?([;'BKM)D>\6ZUV6@Q^Q-;
M'06R'L?7W6X3:I!1443W-]I-*J=$U1&M1SWJUC7.0,)7,?E_N9S/W?N6Z&X$
MRVZV4Z.IL$P2&>66@L-L1R*V&'OT[I7Z(Z>;M19']=&M1K6QU(A$\ !>AX2N
M;,VRN\?_ /;9G=V5FUV^%9&W%99Y4;#:,M<Q(8%;W*B(RX(UM.]$U59$A5-$
M[E4DPV'%8? ;I[HX)LKM]E.Z.YF0PXM@^&TKJN_7J?N5L<:.1C6,8Q%=))(]
MS61QM17/<J-:BJJ(!AY\AOD-W YQ;@(QB5&);'XE42+MUMTLB:N718OQC<?9
M*K9*R1JJB(BJV%JJQBKJ]\D;B%<P4     #7)^SU_#/O5[].^K]O$,V7]%9
M %9'F/\ LW^1GZ(?7RRA886"-@  !V*UXWVVUV8XWV+>W=+(8L0P:U8[:JVM
MJYU[I7.J*")\5-#&WUIIY'.1D<;$57.]!738W^?ODVW=YJWZMQN@FJ-O-@+?
M.BX[MG!+VRU_LG=S*J[RQ+I43*J(YL2+[*+1$:BN1TCXW$*R0H
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ML(W:V_N*77#\^M\%QL=5T1Z1S-]:*5J*O9+$]'1RL]+7M5J]4*PY%
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ME3#$B>AD-52K*[7]]/\ +\B&;-#960      $%?)I\!/*+W8G^DPA88"R-@
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M(86)ZL<,3$1D4;?5:U$1.B$;<;              _K7*U4<U5:YJZM<G145
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M7NM^3,6^KM(26ZJH0H  YUXN_$QQV]^L1^L%("78TE=,
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M-F-WZNJ;59#>[4RDS5R:(OX\M4CK97N5J(G;[2:!TK4_X+D5.BHI6)2V"
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MCR_=JYTZ1YEN]6T[$N%4K]'/@I&JK_FE)W(FD3%U=HBR.>Y$5*Q,I]!
M /29)C6.YC8;KBV6V&CRC&K["^GO6/W"FAK**KIY$T='-!4->Q[5^5'(J 95
MO)7X;ZO:NCON_'$RU55ZVYHV2U>=;1(]]776&%B.DDJ[<Z5RRU%&U$]>)5=+
M%U<BOCU]G&HEGE#0    /L-OL/K]P\^PC +4JI<\YO%LL]N5&]RI/<ZV.BCZ
M=-?6D3H!V3%@L=LQFQ67&[+3)1V?'Z2FH;31M_!BIJ2%L$3$^\UC$0KIO;
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M@VC=69KDTR(J^P98X=*%_P!S_P!8STK>OW3Y7UGYU&B\OYNWXLS"D?\ %O\
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M@Y3\?=QV2^QI\7RVR2W9W=V=UNFKHZ6M9W?)WT\LC=5Z=>NJ= DNQ.*P
M     .OD\@OQP<K/?O(OSC(1N$/ H  O3_9]OC+W,_W8WGZU8X(2S865@
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MR6[&;:KF8QCO?JRGB7HLC^WHZ:335[ODZ-3HB'=5KA#RF1D12.]P::=P
M                           &U3]G>XF5.UG'O,.3666Q:7*>051'386V
M5NDD.*6:62-DK4<B.;\\JW2.5%U1S(HG)T4X9_W!>:XU7,*Z/+GX<F,;?QS_
M (1AZYF'-_\ MP\H3I.77UV9&%\^<*_P5_ZIQ]41+1.<>W)$
M##_YK?M"]UOR9BWU=I"2W55"%  '.O%WXF..WOUB/U@I 2[&DKI@
M     *T.??DQVBX58]6V"CJ*;<'?NO@1V-[80SZMI/:Z=M5=9(=5IX41>YK.
MDDO1&HC55[2Q#$[O%O!N%OWN3E6[.Z>0R9-F^8U'SB[W.1$8U$:Q(HH88VZ-
MCABC:V..-J:-:B(A&W&0    UV^![BM-MMLME')/*[7\VRG>Y[:/"O:L5LT&
M+VZ9VLB=VBHE;4M5^FFBLBB<BZ.$,VE?B5D   (>>0;X'N5GN+D7YND"PZ^0
MC8   6L>)+A3%RUY#1W[-;4E;LMLPM+=L[AE8CJ>Z5KY%6WVMR.U[FSOB=),
MFBHL4;FKHKVA)EN$8QD3&1QL2..-$;'&U$1K6HFB(B)Z$0K#_0         !
M0%^T%;54V0<>-H]WZ>G[[MMMD[[753(U/5MF14+W2.<[TZ-J+? UJ?\ &4DM
M59'@T   '8'>.K+79MP9XM7MTJS/I\.M-LDE7JJNL</XD=JJHFJZTG5?_&OI
M*Q*: 0    %6?F9K[G!X_=V;3:(IZBMRBOQFA;2T\,TTLK&Y#25[VHD**J)V
MTR]RKT5-4^4+#$I_4G,_^R-S_P"@57^C(WB?U)S/_LC<_P#H%5_HP8G]2<S_
M .R-S_Z!5?Z,&)_4G,_^R-S_ .@57^C!BW)^(_ /]GG '8FAJ+<ZVW?(HKQ>
M;XR1GLY9)KC?*N2)SVZKHJ4Z1,Z]=&IJB+T*Q*R0(         /SEBBGBD@G
MC;-#,U630O1'->UR:*BHO145/2@'7*\F-LV[,\A][MJ88UBHL RF^6NTZ]%=
M0TMQECI7]?D?"C')^Z1U'!X  !>7X!<PELG,/-L5?.K:+-L&N;&TW<J(^LM]
MUMU9$[3T*K8DF1/W5Z_(J&;-B960      %<7EMQIF4^/3D;2+#[::V45HN=
M,Y.Q'1K;,BM]<]R+)T3^#C<BZ=5151.JA88/B-@  !;/X@^&%/RIY%LRO-K4
MVX;/;'K2W;+Z29BNI[G<I)'+;;<Y%31S'R1.EF:NJ+'&K%_#0),MNY6
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M*BT;<RR6+:N*5J*Q]]J:5'UU8B.^6FIIV1QKU173.5-'1H(9LU9E9
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M],:L"JG<B.]59YU;JCIGHG[C4Z)\JN[JM<(>3T^1X=L[T?33N@
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MS3931OED>KU<UN6W.=G;KU1K62M8B?)I]PK$K1 @
M   PA^76STMC\BG)*BI$1L4]7C]8]$8UB>UN&)6JX2=&]->^9=5]*^E>JD;A
M6Z%  %L_A+JZBF\@VVD,$JQQ5]GRB&L9HGKQML51.C5U3_AQM7I]P0EFW<K
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MY;!8%=HZ5R:M^<U/:JHZ5R+T3JC$71-55SG=U6L1#R.GT_AVSO1O-.[
M                          "2/%/BKN]S&WBQ_9G9RQ+<KW=%2:^WR5'M
MMMCM;'M;/7UTS47V<,7<GW7/<J,8CGN:U?7/-/FG2<GT=M1J)PK&Z.-IX1$=
ML_9OG8]F\I>4M9SK6UTVFKC:=\\*QQM,\(C[=T;9=AKPNX:[2<'=EK3L]M52
M/J7*]*W-\TJ6M2XY!>'Q-CEJZCM548FC$;%$U>V-B(B:KW.=^?WG+SCJ^=ZV
M=1G^BM8W5CLCWSQGV/T:\D>2M'R'0QI\B.^UIWVMVS[HX1[4M3U-[@
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MV   &UGP9_ 5C_O/DGTF,K$KA0@          05\FGP$\HO=B?Z3"%A@+(V
M  &VKP@7%];P P>F?&C&V>_9-3QN15U>UUT?5ZKK\NLZI_D*Q*W0(
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MZL\NMHMRHL;ZR5J=OSFH;KU5>OLVK^"WY.Y5.YI3!Y+3Z?P[9WHN&W=
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MS-P]*>]               &'_P UOVA>ZWY,Q;ZNTA);JJA"@
M          $N.)'"G?3F9FS<6VHQY8[%;Y&)E^XE<V2&R6:)VBJLTS6N[Y5:
MNK((T5[O3HC=7(29;7>&'"#9[A+MTW#]O*1;SE=X;')GVYE9#&VZ7JJ8U/3V
MJ[V-,Q=?8T[7*UB+JJN>KGNK,RF2$      AYY!O@>Y6>XN1?FZ0+#KY"-@
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MP       AYY!O@>Y6>XN1?FZ0+#KY"-@  !M9\&?P%8_[SY)])C*Q*X4(
M        "LCS'_9O\C/T0^OEE"PPL$;   #>;XG?L].-'Y,NGUBN!6)6(A
M         IZ\YGP%9![SXW])D"PQ3$;   #?IXR_@)XN^[$'TF8K$IU!
M       JA\UWV>FZWY4Q;ZQ4@6&'\C8   ;]/&7\!/%WW8@^DS%8E.H(
M    =?)Y!?C@Y6>_>1?G&0C<(>!0 !>G^S[?&7N9_NQO/UJQP0EFPLK
M  ""ODT^ GE%[L3_ $F$+# 61L   -P'A1^STVI_*F4_6*K*Q*UX(
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M]T<ETF:NB3S-731B:?P3%ZI^$[JJ(WNJ4P>1TV1AMG>B2;=X
M                   '-''WC]NGR?W9Q39?9O&WY+F^6S*RFAU6.EHZ:-.Z
M>KJYM%2&G@9ZTCU^3HB*Y4:OAN?\_P!+RS26U&HMX:5]LSPB(XS/!YOR[Y=U
M?-=973::OBS+>R(XS,\(CC/O=@KX\_'[MAP!V?;A>+/;D^X^4I!4[K[FR1)'
M47>NB8J-BA:NJPT<'<Y((M>FJN<JO<Y5X"]0//VJY]J_S+_#EUV4KV1W]LSQ
MGU;H?HETYZ=Z7R]HORLOXLVVV]^-I[NRL<(]<[93^/0GT,
M  8?_-;]H7NM^3,6^KM(26ZJH0H                   ')6UFS>ZV]V2PX
M?M%M[=]Q<DF5G=;+313U;H6/=V)).^-JLAB1?3)(YK4]*JB :&N(?@0K9)[3
MFG,;*64]*Q63+LMC]4KY9.J.]E<;K"J-8G14?'2=RJBZMG:HP9FS2-M[MS@>
MT^)6C ]M,1H,'PZQ,5EJQVVTT=+31(J]SG=L:)W/<O5[W:N<NJJJJNI67V@
M      $//(-\#W*SW%R+\W2!8=?(1L   -K/@S^ K'_>?)/I,96)7"A
M      @KY-/@)Y1>[$_TF$+# 61L   -K/@S^ K'_>?)/I,96)7"A
M    ^+SS<C;W:RP3Y5N7G%HV_P :IETFOMYN-);:1'::HU):R2-JN7Y&HNJ_
M(@%3&]7G.X9;:2U5MP!]\WRO,&K6RV:A^86I)$U16OK+RM.Y4Z?A0PR-7Y%4
M+$*P-SOV@_D%?7U5/M-LSB^WE!-JV&KNTUQR*OC37HYKXGVV!'+_ ,:%R?\
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M3                  P_P#FM^T+W6_)F+?5VD)+=54(4
M^\QG:W<[-5C3#=N;]EJRHU8DMEHN%?W(Y'*FGS6*377L73]Q?N Q2IP3QI<\
M=Q70I8.+^44#9OP)+Y2Q8TS1'=NJKD<E#HGRI]U.J= F*?&UG@#Y3Y4ZEJ=T
M-P,6VGMLJM^<TL4M5D%UA:O5R^PHV04SE3Y$2KZK][J,$\2U/8_P3<0=MI*2
MY[G5U[WXO=.J.DIKC4K:+*KV]6N;1VAS)EZ]5;+4R-7T*FFNMP3Q+=]O]M-O
M-J,=I<1VRP>U8!C%&B>PL5HH*:WTR.1$;W*RF8Q'/73UG.U<J]555"/MP
M      "'GD&^![E9[BY%^;I L.OD(V   &UGP9_ 5C_O/DGTF,K$KA0@
M      05\FGP$\HO=B?Z3"%A@+(V   &UGP9_ 5C_O/DGTF,K$KA0@
M !QONON_MCL;A=SW#W<S:@P'#;2B?.[W<)O9L<]R+VQ1,:CI)I7Z>I%&USW?
M(B@9J^6_GORJ\3U^(\/\5;BEH:KXI-V,AI8JFYS:*K4DH;<YTD$+>FK75'M%
M5%ZQL4F+454 [F[N;H;SY+49ANQGUVW#R:HU1UWNU=/6RL8NG\'%[9RI'&FB
M(C&(C43HB(&G'8               "U[PI?:%[4_DS*?J[5B$LW %8
M 0\\@WP/<K/<7(OS=(%AU\A&P   VL^#/X"L?]Y\D^DQE8E<*$
M !61YC_LW^1GZ(?7RRA886"-@  !O-\3OV>G&C\F73ZQ7 K$K$0@
M  4]><SX"L@]Y\;^DR!88IB-@  !OT\9?P$\7?=B#Z3,5B4Z@@
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MO3KZ%0^R\H\Y\IU\?H9]+S/#Q1C_ ,LX3]CXASGR/SCE\S_49%Z1''PS-?\
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MI6?E[Y_%V1\OIW<&>N76W^O\7+M!;]#=>\?/^&OX>V?F_A^]58<B'%@
M           ?G++%3Q2SSRMA@A:Y\TSW(UC&-357.5>B(B>E0*BN5')VHW"K
M:W ,%KEBP&B>C;G=(G.:Z\2L5%7KT7YNQR>JW]^J=RZIVHG<TI@[_3Z?#;*$
M)U'?                               !][M?M?G^].?XMM;M;BU5FF>Y
MI5,H\<QRC8CYIYGHKE55<J-9&QJ*^21ZHQC$5SE1J*J=AS/F>GT>GMG9UHKE
MUC&9G]O9&^9V0\ARKE6HUVHKD9%9OF7G"(C]MW;.Z(VRW]>,?QI[?<!=KX:B
MM@I<IY#YM20_[4]Q6M]HV'7MF6UVUTC6NCHH7HFJZ(Z9Z=[]$2-D? SJ7U(U
M'/M3A&-=/2?AK_-;\4_9&R.,S^A?2WIAIO+VEQG"VIO'QV_EK^&/MG;/"(M$
M/F+ZJ                  ##_YK?M"]UOR9BWU=I"2W55"%  '-W&>EI:[D
M?Q^HJVFCK**LS?%(JNDE8V2*6*2_4K'L>QZ*CFN15145-%0$NPB_V)[,_P!T
M>,?S!:O] 5TS_8GLS_='C'\P6K_0 /\ 8GLS_='C'\P6K_0 /]B>S/\ ='C'
M\P6K_0 /]B>S/]T>,?S!:O\ 0 /]B>S/]T>,?S!:O]  _P!B>S/]T>,?S!:O
M]  _V)[,_P!T>,?S!:O]  _V)[,_W1XQ_,%J_P! !]':,$P?'TITL.&VJR)2
M.5]*E';J.F]DY5555GL8V]JJJ^E /JP               $//(-\#W*SW%R+
M\W2!8=?(1L   -K/@S^ K'_>?)/I,96)7"A           @KY-/@)Y1>[$_T
MF$+# 61L   -K/@S^ K'_>?)/I,96)7"A       $!.=OD'VCX.X6VIR%[<P
MW7O\+GX+M135#(ZNJ1>]C:JK?H]::C:]BM656JKE16L:Y4=VEB&*WDURQWOY
M<9Y/GN\^727F:-TB8[C$'?3V:RT[U1?84-(CG-C;HB(YZJZ1^B*][EZD;P1N
M                  %KWA2^T+VI_)F4_5VK$)9N *P       AYY!O@>Y6>
MXN1?FZ0+#KY"-@  !M9\&?P%8_[SY)])C*Q*X4(           "LCS'_ &;_
M ",_1#Z^64+#"P1L   -YOB=^STXT?DRZ?6*X%8E8B$          "GKSF?
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M^+LCAQV[N$?6KKM_6Q;0<MM^ENOF1\_X:_A[9^;='P_>J>.1SBB
M       /\O>R-CI)'(QC$57O541$1$U555?D J>Y7<H/ZZ2U6W&W=Q<W$:=S
MH\DOL3M$NLC5T]E$Y.OS=JIU7_.+_P 5$[NYRZ8.^TN1\T^I LZCOP
M                         ^QV]V]S;=?-L9VXVXQFKS'.<QJXZ'&L:H8U
MEJ:NIE7HUJ=$1$1%<][E1K6HKG*C454[/F',,G2Y-L[.M%:5C&9G=$.]Y=R[
M/U>?7)R:S?,O.$1&^9_;V-[OBM\8.(\"=NWY)E[*/+.2F>4[/Z]YG&Q)(;12
MO1LGXHMLCT[D@8YJ+-*B(LST15]5L;6\$NJ/4S-Y[J/!EXUTU)^&O;/U6[^R
M.$=\R_0/I-TLR?+^F\>9A;57CXK=D?37N[9XSW1&%MI\H?8
M       ,/_FM^T+W6_)F+?5VD)+=54(4  <Z\7?B8X[>_6(_6"D!+L:2NF
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M_AC^:=O9AMAP-ZH]<-=S^9R,G')TOTX_%;^.8_VQL[<<(E!8^O/A@
M         _BJB(JJNB)Z5 JPY7<I69*EPVPVWK^['FJL6591"]?]?5JZ.IZ=
MS5_B->CWI_&>A/4U5_<Y>7AOWN[TV1XOBG<KX.H\D
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M"2W55"%  '.O%WXF..WOUB/U@I 2[&DKI@
M0\\@WP/<K/<7(OS=(%AU\A&P   VL^#/X"L?]Y\D^DQE8E<*$          "
M"ODT^ GE%[L3_280L,!9&P   VL^#/X"L?\ >?)/I,96)7"A     >)7U]%:
MJ&MNESJXZ"VVV&2>X5\SVQPP00L6221[WJB-:UJ*JJO1$ P*^0[F!>>9?(W)
M\^952LVYQMTEHVDLC^YC::RT\J]L[F+Z)JMVLTJKU3N1FO:QND;B$%@H  ]E
M9K-=\BN]KL%@M=1>[[>ZB&DLUFI(9*BJJZJHD2**&&*)'.>][G(UK6HJJJZ(
M!ITX->"VT4]#9]R>:+WW"YU#63V_8J@JW14],BZ.:EVK:-Z.D?\ =@IWHU.G
M=(_56(P9F6BS",#PG;3&K;ANWN)V[",3L[>RV8[:J."AHX4^7MBIFL;JOI5=
M-57JNJE9?6         ,+/F/^T@Y&?HA]0[*1N%8X4  6O>%+[0O:G\F93]7
M:L0EFX K       "'GD&^![E9[BY%^;I L.OD(V   &UGP9_ 5C_ +SY)])C
M*Q*X4(           "LCS'_9O\C/T0^OEE"PPL$;   #>;XG?L].-'Y,NGUB
MN!6)6(A           IZ\YGP%9![SXW])D"PQ3$;   #?IXR_@)XN^[$'TF8
MK$IU!           JA\UWV>FZWY4Q;ZQ4@6&'\C8   ;]/&7\!/%WW8@^DS%
M8E.H(        =?)Y!?C@Y6>_>1?G&0C<(>!0 !>G^S[?&7N9_NQO/UJQP0E
MFPLK       ""ODT^ GE%[L3_280L,!9&P   W >%'[/3:G\J93]8JLK$K7@
M@          05\FGP$\HO=B?Z3"%A@+(V   &X#PH_9Z;4_E3*?K%5E8E:\$
M   "*_.6S2Y!PQY5VNG[EJ)=O<NEIHV-[WR24UBJ:ED:)]UZQHW_ "@AUY)'
M4   #9GX%;XEVX/72@]HC_ZLYU?Z%6]JM[/:6^V7+157\+_G>NOW]/D+#$KJ
MP@            &%GS'_ &D'(S]$/J'92-PK'"@ "SCPX?:0<<_TO^H=Z"2W
M3%8              1"Y5;4[@7NT0[L;%WNJQK>G!*=R4GS-4_Z]M3'+.^WS
MPO1T<_:Y5D@9(UR=RJW3UM4^F=._,6BRLW^CYA6+Z3-G;C\EMWBB=\=EIB8V
M;>#Y%U4\J\PS\F-=RR\Y>MR8V>'_ +E-\TF-UMNVL3$QCC''%#C9WRD4NE-8
M]]\,DHJN)4BFS"RL[F*Y%[56HH9W(YFFFKEC>[5?0Q#ZAYG_ +>[;<SE^9C'
MTW]UHW]V,1Z7QWR?_=%79E<SRIB=WCI[Z3MCOPF>ZJR[;G?+:+=J!DVWFX%M
MR:9[>]UKBJ&QU\;43N59*2?LG8FGRN8A\&YYY1YGRV<-3E6I';,?#ZK1C$^U
MR5\N>>.4<VKCI,ZF9/9$_%ZZSA:/7#E8]<>U      <);F\C=DMGXZA,^W$M
M]IN%.GK6".7YY<U735$^:4:2S)K_ ,)S4;]U4/;.0>1N;<SF/Z?)M:L_-NK_
M ,TX1]N+TKS-U&Y)R>)_JL^M;1\L3C;_ )8QG[,.]6#O/Y2;O7-K+-L9B?XD
MA=W,9FEY;'-5_<[X**-SXF+\J+*YZ*GI8BGW_P K?V]Y5,+Z_,\4_139'KMO
MGU1'I<8O.?\ =%G7B<OEF7X(^N^$SZJ[H]<SZ%5V89MEVX%]J\FS;(JO*+]7
M*JU%SK)GS2::JJ-;W+HQB:^JQJ(U$Z(B(<B.6<ITVBR8RLBD4I'"(P_^9[YV
MRXL<XYUJ^89\YVIO;,S)XVG'_P"([(C9'!\N>0>+                 "LK
MEARFDGDNFU>VU>L=-&KZ?,,IA?UE7\%])3.:O1J>B5Z>GJU.FJN[C+R\-LN\
MT^GQVSN5NG5>1                               #VECL=ZR:]6G',<M
M-3?L@OU3!1V.QT<$E35UE74R)#%##%"CGR22/<C6M:BJJKHATL_/IE4F]YB*
MQ&,S.R(B.,NKD9%\V\4I$VM:<(B-LS,[HB.UND\1_B<QWAKBMJWLWEME/?\
ME'EE$USHWI'/3X31U</KT%(Y%<UU8YKNRJJ6JJ>F*)?9]SY>$'5CJKF<XS9T
MVGF8TM9_YYCC/=],>N=N$1STZ/=(LODF5&IU,1;5VCU9<3PC\7U3ZHV8S-X9
M\3?=P                     ##_P":W[0O=;\F8M]7:0DMU50A0 !SKQ=^
M)CCM[]8C]8*0$NQI*Z8                          $//(-\#W*SW%R+\
MW2!8=?(1L   -K/@S^ K'_>?)/I,96)7"A           @KY-/@)Y1>[$_TF
M$+# 61L   -K/@S^ K'_ 'GR3Z3&5B5PH0    %1/FHY%3;(<.+WA]CKEH\O
MW\JDQB@5BI[5EI=&M3=I$1?WKJ=OS9WRI[9%3[H6&)<C8   :Z/#!X]K)M=M
MY8>6.ZU@CKMU]Q:5*K:ZAJF(_P#J[CU5$OLJJ-KDT;55\;^_OZJR%6M16J^1
M%,S*_8K(          86?,?]I!R,_1#ZAV4C<*QPH  M>\*7VA>U/Y,RGZNU
M8A+-P!6       $//(-\#W*SW%R+\W2!8=?(1L   -K/@S^ K'_>?)/I,96)
M7"A            5D>8_[-_D9^B'U\LH6&%@C8   ;S?$[]GIQH_)ET^L5P*
MQ*Q$(          %/7G,^ K(/>?&_I,@6&*8C8   ;]/&7\!/%WW8@^DS%8E
M.H(          %4/FN^STW6_*F+?6*D"PP_D;   #?IXR_@)XN^[$'TF8K$I
MU!        #KY/(+\<'*SW[R+\XR$;A#P*  +T_V?;XR]S/]V-Y^M6."$LV%
ME8       05\FGP$\HO=B?Z3"%A@+(V   &X#PH_9Z;4_E3*?K%5E8E:\$
M        ""ODT^ GE%[L3_280L,!9&P   W >%'[/3:G\J93]8JLK$K7@@
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MS&,,_4WF)X1/ACV5PC[' JJJJJJNJKU55]*J>XO0W\"
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M.8_ECA''?/##G7T9Z05Y1EQJ]76)U5HV1O\ RXGA_%/&>&Z..-^)\(<@@
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M1L   -^GC+^ GB[[L0?29BL2G4$        .OD\@OQP<K/?O(OSC(1N$/ H
M O3_ &?;XR]S/]V-Y^M6."$LV%E8       05\FGP$\HO=B?Z3"%A@+(V
M&X#PH_9Z;4_E3*?K%5E8E:\$          ""ODT^ GE%[L3_ $F$+# 61L
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M[2$ENJJ$*  .=>+OQ,<=O?K$?K!2 EV-)73
M  AYY!O@>Y6>XN1?FZ0+#KY"-@  !M9\&?P%8_[SY)])C*Q*X4(
M $%?)I\!/*+W8G^DPA88"R-@  !M9\&?P%8_[SY)])C*Q*X4(    #![Y;,F
M?E7D*Y&UBRJ^&V5UIME,SUT;&VUX]04+FHC_ $:OB<Y=.BJJJGI(W"N,*  +
MF/!+9J*Y\[(*VK8KI\=P_(JRV.]7U9WOI+>JKJB_YNJ>G31>OW-45"6;1BL
M           PL^8_[2#D9^B'U#LI&X5CA0 !:]X4OM"]J?R9E/U=JQ"6;@"L
M       (>>0;X'N5GN+D7YND"PZ^0C8   ;6?!G\!6/^\^2?28RL2N%"
M        K(\Q_P!F_P C/T0^OEE"PPL$;   #>;XG?L].-'Y,NGUBN!6)6(A
M           IZ\YGP%9![SXW])D"PQ3$;   #?IXR_@)XN^[$'TF8K$IU!
M         JA\UWV>FZWY4Q;ZQ4@6&'\C8   ;]/&7\!/%WW8@^DS%8E.H(
M      =?)Y!?C@Y6>_>1?G&0C<(>!0 !>G^S[?&7N9_NQO/UJQP0EFPLK
M    ""ODT^ GE%[L3_280L,!9&P   W >%'[/3:G\J93]8JLK$K7@@
M    05\FGP$\HO=B?Z3"%A@+(V   &X#PH_9Z;4_E3*?K%5E8E:\$    !BE
M\XNV$F!<ZL@RF.G6*W[OV"QWZGD1/X-9Z>G7'YVIHFB.[K<CW)Z?71?E(W"G
ML*  )$<2MYW\>N2VRF\OM',H<$R"AJ+^C->]]IF?\SN,;=$7J^DFE:G1?2!V
M)]+54M=2TU;15,=915D;):2KB>V2*6*1J/8]CV*J.:Y%145%T5"NF_<
M       ,+/F/^T@Y&?HA]0[*1N%8X4  6<>'#[2#CG^E_P!0[T$ENF*P
M             %27.3@VF2)=]Y]F+1ID2=]3G&#TS.EP3J^2LHXV)_SCY9(T
M_C/PF^OJC^2?2/JY^1X=#KK?!NI>?E[*VGZ>R>&Z=F[B7UPZ'_U/BYCRZOZF
M^](^;MM6/J[8^;?'Q?>I)5%1514T5.BHOI13E@X3OX$
M     (&\JN4<>%PW#;?;VM27,*ACHLAOT3M4M3'MT6.)S?\ [RJ+U5/XO_E?
M@];+R^,NYR-/XML[E3;G.<Y7.57.<NKG+U554Z[R<1@_@4
M                ?UK7.<C6HKG.71K4ZJJJ!LE\-WA]BV=AQ7EGRAL#9]VZ
MED5?M'MA5-1S,6CD:DD5QKF+JBW%S51T42]*=/67^&T2'A]U@ZN3K)MH=%/Z
M6Z]H^;\,?A[9^;^'?S3Z+=&8T45YAKJ_K;Z4GY.RT_B[(^7^+[NE4XX.3H
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M!4345$]7/-554SZFIJ7NDJ*B1RODDD>JN<YSG*JJJJNJJIUWE(C!^04
M                          -=_AA\0%/BE+BW+_E5BKG9E,L5?LIM'<H$
M1MHCZ207BY02]5JW='4L#T_@4TD<GM5:D7$OK'U<G-FV@T-O@W7O''MK6>SM
MGCNC9CCS%Z)=&XR8KS'7U^/?ETGY>RUH[?ICAOG;AAJ,.,;E6
M               !A_\ -;]H7NM^3,6^KM(26ZJH0H  YUXN_$QQV]^L1^L%
M("78TE=,                          "'GD&^![E9[BY%^;I L.OD(V
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MLMUZLU?#=;/>((:JU72GD9-3U--41I+%+%)&JM>Q[7(YKD71475"L//
M     *P?*9SFM_#K8>MMV+W-J;Z;JP5-NVSH8W,6:VQN9[.IO$B+KVLI4>GL
MM47NF5J:*U'JTL0PR3SS5,TU34S.J*BH<Y\\[W*][WO7N<YSG:JJJJZJJD;?
MD   6<>'#[2#CG^E_P!0[T$ENF*P                   !5?S:X+MW!?<M
MV]F[:R#.-))\OP^)$8R\]K5>ZHIFHFB5:Z>LWT2^GH_7OY#])^KO]%AH];..
M3NK;Z>Z?P]D_+Z-W%GK7T,_]A-M?RZL1G[[TCY^^OX^V/FW_ 'OO4830S4TT
MM/41.IZBG<YD\#VJQ['L7M<US7:*BHJ:*BG+JEXM&,;8EP;O2U;3$QA,/R-,
M                 !#;E'R8IMK+?+AV&U<=5N+<6)[>5$;(RT4\C=4ED1=4
M69R*BQL7T)ZSNG:CNKEY>.V76R<GQSW*>:NKJKA55-=75,E96UDCY:NKE>Z2
M6661RO<][GJJN<Y5U55])W#RM:Q$80\<-
M    !JZ\+GB#D63&N87*W$$2)$@K]B-IKE$O<KM4FAO=RIY4Z(G1U'"].O\
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M>VM9[>V>&[?NY4]$^C4YTUYCKZ_!&VE)C[W9:T?3],<=\[,,=>IQ)<QP
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M! SN7MCC:C4557355533B4     +./#A]I!QS_2_ZAWH)+=,5@
M            K3YK<(*'=BCN&Y^U-MBMVY]&U\M[L<360PY Q-7N7IHUM6G[
MUZ_QGH=UT<GWGI3U9ORVT:35S,Z>=D3.V:?_ (]W#?'8XU]:NB.7S:EM;H:Q
M751MM6-D9G_Y]D_-NGA*@^KI*J@JJFAKJ:2BK:*1\591RL='+%+&Y6/8]CT1
M6N:J*BHJ:HIS'R\RMZQ:LXQ.V)C=,.!6;E7R[S6T3%HG"8G9,3'"7CFW3
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M'%&R*)B111(C8XVHC6M:U-$1$3T(AP\F<7-6(P?[(H
M          !A_P#-;]H7NM^3,6^KM(26ZJH0H  YUXN_$QQV]^L1^L%("78T
ME=,                          "'GD&^![E9[BY%^;I L.OD(V   &UGP
M9_ 5C_O/DGTF,K$KA0@          05\FGP$\HO=B?Z3"%A@+(V   &UGP9_
M 5C_ +SY)])C*Q*X4(    #^.:US5:Y$<UR:.:O5%10,.?E>X/57$;?RMR'$
M+.Z#8S=Z>IN6W\\4:_-K55N=[6KM#E35&^P<[N@1?3"YJ)JK'Z1N)57!0
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ML       (*^33X">47NQ/])A"PP%D;   #<!X4?L]-J?RIE/UBJRL2M>"
M       !!7R:? 3RB]V)_I,(6& LC8   ;@/"C]GIM3^5,I^L565B5KP0
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M_P!G&T*X.        LX\.'VD''/]+_J'>@DMTQ6
M  !6WS3X04F\D59N7M=2P6S=*FC5UXM.K8:>_P <;.B*OX+*I$31CUT1_1KU
M3HY/NO2KJU;E<QI=7,VT\[IWS3_&O;'#?'9/&_K1T1ISF)UFBB*ZJ(VQNC,B
M/W7[)W3NGMB@RY6VXV:X5EJN]!-:[I;I'PU]NJ(WPSP2QKVN8]DB(YKD5-%1
M4.9.1GTS:1>DQ:L[8F-L3'=+@3J=-F9.9-,R)K:LX3$QA,3V3#PCJN@
M     $9>0_(ZP[,6B2VV]\5XW!N,>MHL>O<RF:]%1*BJ[5U:Q/WK=45Z]$T3
M5R=2F7BZF7E3>=BEO(<AO667JXY%D5QDNUZNTBRU]?*NKWO7I\FB(B(B(UJ(
MB(B(B(B(=R\M2D5C"'I@V                               &AOPW>(U
M_)2Y6WDSR4QR>FV!L<[)=OL)J8UB3-JR&1W=+*CE1WXM@<Q$=TTG=ZB+V->B
M\?NL'5C_ -;6='H[?^1/WK1\D?\ 5/\ IW[YAR-Z+='O_9VC6ZVL_P!/$_#6
M?^Y/?^&/]4[-T2VL4E)26^DI:"@I8Z*AHHV0T5%"QL<4,4;48QC&,1$:UJ(B
M(B)HB'#*]YM.,[9ESAI2*Q$1&$0\@RT
M ,/_ )K?M"]UOR9BWU=I"2W55"%  '.O%WXF..WOUB/U@I 2[&DKI@
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MUG<J1^S6HAD5$T3VC7N5&L54)+9N5@     "'GD&^![E9[BY%^;I L.OD(V
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MD')3CKCRU6S5TE=4Y_M_10JK\3J)5U?4TT4:+K;GN756M3^ 5=-/9:=D;B5
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MKE7O=+6U\\CI9I9'+JKGO>JJJK]U3K/(UK$1A#PPT
M            %]?A^\2MWY89)9^0>_EBEMO&+&ZES[/8ITE@GSBNIG*WV$/:
MK7-M\4C=*B9/XQ46*/K[1T?PKJYU7IRK+G2Z6<=3:-L_1$\9_%,;HX;YX1/(
M'HUT@OS?-C6:NN&EK.R/_P!DQPC\,3OGCNCC,;@K9;+;9+;;[-9K?!:+/:((
MJ6U6JEBCIZ:EIJ>-(HHHHHD:UC&-:C6M:B(B)HG0X3YN;:]IM:<9G;,SOF7.
MO*RJTK%:Q$5B,(B-T1V0\XPZ@                               8?\
MS6_:%[K?DS%OJ[2$ENJJ$*  .=>+OQ,<=O?K$?K!2 EV-)73
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M$      AYY!O@>Y6>XN1?FZ0+#KY"-@  !M9\&?P%8_[SY)])C*Q*X4(
M       "LCS'_9O\C/T0^OEE"PPL$;   #>;XG?L].-'Y,NGUBN!6)6(A
M        IZ\YGP%9![SXW])D"PQ3$;   #?IXR_@)XN^[$'TF8K$IU!
M      JA\UWV>FZWY4Q;ZQ4@6&'\C8   ;]/&7\!/%WW8@^DS%8E.H(
M   =?)Y!?C@Y6>_>1?G&0C<(>!0 !>G^S[?&7N9_NQO/UJQP0EFPLK
M ""ODT^ GE%[L3_280L,!9&P   W >%'[/3:G\J93]8JLK$K7@@
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M4]5C6M1$*QBQN^8_[2#D9^B'U#LI&X5CA0 !9QX</M(..?Z7_4.]!);IBL
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M8XC>[=C5DC?%')55E51/BBB:Z=[&(KG*B:N<B??!#&5^J>\A?^&BZ?SICO\
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M9[N8K-A><V>OR":Y8_/-2SR11UE[J:J%ROHY9HU[XWHY-'?+U*S*Q((
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M!'[ 86?,?]I!R,_1#ZAV4C<*QPH  LX\.'VD''/]+_J'>@DMTQ6
M                     !$3FEPMV=YR;.W':C=>W>PJX/:5.!9[31L==,=N
MCF=K:FF<[3N8[1&S0N7ME;T714:YOMODWSEK.2:R,_(G9NM6=UH[)]T[XGUP
M].\[^2-%S[13I]1&W?6T;ZSVQ[XW3'JF.OVYG<+MY>#F[U=M3NY:TDAJ$?4X
M/G5(R1;3D-M1_:E32R/1-'-U1LT+O7C=T75%:YW/?R=YRT?.])&?D3W6K.^L
M]D^Z=TOSP\[>2-;R'63I]1'?6T;K1VQ[XWQ/J1(/;'IX
M                  "Y'Q.^+#(N=>:.W#W'958QQCP2L9'DMWC22"JR:NCT
MD6UV^71.UJ)I\ZG:NL;51K?7<BM^/]5>J&7R/)_*R<+:F\;(X5CZI]T<>.R-
MOVGI%TGS.?Y_YV=C72TG;/&T_37^:>'#;.S>)A>%XGMUB>/8)@F/4F)X=B=)
M#0XWC=#"RGI*.DIV(R.**-B(B(B)_E]*]3@QK-9FZC-MFYMIM>TXS,[YES]T
M6BR=-DURLJL5I6,(B-D1$/ICMG=
M
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MNE32M;I)6T[&JV.55TZHYR.>R-S"XIDA
M
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M\'N+8^],4L.35[W>R]IVI):WVO7NU3LZUB)W??[?E$)9MJ*P
M                   $8>6O$39;FCM+<MHMZ; MPMDKEJ,;R2F5D5VL5R:Q
M6,K*&=S7=DB(NCFJBL>W5KVN:NA[-Y4\VZWDVKC/T\X3QB=UH[)C]IC?#U;S
M?Y.T/.]'.GU-<8WQ,;ZSVQ/;]D[I=?GSEX-;P<$-X*S;3<NC6YX]<UFJ-MMR
M:>%[+9D5L8]&^UB[E=[.>/N:VHIW.5T;E3JYCF/?SX\D>=]'SW1QG9,X6C9:
ML[ZS[XGA/'TXQ'YW^?/(>MY!K9R,^,:SMK:-UH]TQQCAWQ,3,+CW)Z0
M                           "V;Q8^,3,^>FY,>0Y73UF+<:,'JFIN%F\
M:>QEN=0QJ2I:+8^1%1U1(BHLTB(J01KW+ZSHVO\ E/5#J7D\BTW@IA;4WCX:
M]GXK=W9'&>[&8^O=)^EF?Y@U7CS,:Z6D_%;MGZ:]\\9^6._")WQ[>[>X3M1A
M.,[<;<8S28;@V&TD=#C6-4,:14U)31)T:U.JJJJJN>]RJYSE5SE5RJJ\$>8<
MPS]7GVSLZTVO:<9F=\S^WL?H+R[EV1I,BN3DUBF72,(B-T1^WM?9'9N]
M
M
M
M
M                          !X5SN5!9K=<+O=*IE!;+5!+4W&ND7MCA@@
MC661[E^1K6M554#K<]X,^J=UMV=T-T*UBQ5>X^0WJ^U,2_O'W>Y35ZM_R++H
M1U''0  !H,_9Z,&DN6_V^VXRTZRTV'XC2VCYPK=6Q3W^[Q5;.J^ASF6F1$^7
M37[XAFS6D5D                                $?N3/&+9WEQM/?]G=
MZL7CR'&KRQSK?<&I&RY6>O1BMBKK?4.:Y8*B)5Z.1%1R:L>CF.<U?/\ EKS-
MK.4ZN-1I[>&T>R8[)CC$_P"<83M>N^:/*VBYQH[:;4U\59W3QK/":SPF/\IQ
MC&'7Z\^/']O)P(W4J,/SNBDO^WE]EF?MANS3T[V6V^4C%[NQW5R05D351)Z=
MSE5J]6JZ-6O=SX\B>?='S[2_F94X9D?>IQK/OB>$_NG&'YX=0>G>M\OZO\O-
MCQ9<_<O$;+1[K1QC]\82@>>\O0                              !9]X
MS?&GN/S\W,9-*RHQ'C_A55#_ +4-R5C5/:*G;,MKMW>G;+6S,5-5ZMA8J2/U
M58V2?,^I/4C3\ATW"VHO'PU_FMV5C[9V1QF/J?2_IAJ?,.JQG&NGI/QV_EKV
MVG[(VSPB=_\ M=M=@&RV 8MM;M;BU+A>!872LH\<QRC8K(8(6*KE55<JN?(]
MRJ^21ZJ][U5SE5RJJ\"N:<TU&MU%L_/M-LRTXS,_M[(W1&R'Z&\JY5I]#IZY
M&16*9=(PB(_;?VSOF=LOOCL'D
M
M
M
M                                          ?-4N98E795>,&HLFH*
MO,\?I*2OON*1U4#[A1T5>^6.GGFIVN61D<KH'HQRIHNBZ ?2@
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MK:C/MXLR\XS/NCLB-T1PA^B'(^1Z;ENDIIM/7PY=(PB/?/;,[YGC+E0\6\L
M
M
M
M
M               " 'D(YX83P>VEDODWS?(=W,N9-3[5X ]^OSFI:W1U95MC
M>U[:.G546145%>Y48U45W<TL0QF[7\T>06UG)*7E3;,VFO>ZUVK)JG,JRO59
M*6^TU4K?G%%60Q*QJTSVM:UK&=J1]K%C[%8Q4C6#<7Q%Y=;4<RMJ*#<W;*O]
MC50^SI\VPFHD8MRL-R5G<ZGJ&MT[FNT589D3MD;U314<UM9F$I@@
M  ?E//#30S5-3,VGIZ=KGSSO<C&,8Q.YSG.=HB(B)JJJ!AF\KO,^GY?<CZEF
M&W%:W9O:)E19=MYF.58;B]TJ.KKHU%^2JDC:V-?EACC541RJA&XA5^%  'M;
M%9+MDU[L^-V"@DNM]R"JIZ&RVN%O=-4U=7,V"&)B?*Y[WHU$^ZH'8M<:]F[=
MQ[V#VDV6MJQR1[=V*AM]?5Q-[8ZJX-B22MJ431/X^I?)*OWW%8ES>$
M                             <0;Z[#[5<E-L<DVAWFQ&FS/!\GB5E7;
MYVI[6GG1CFQU5+*GKP5,*N58Y6*CFKZ%TU0\OR/GNJY;J:ZC3VFMZ_;W3VQ/
M&)>&Y_R#2<STMM/J:Q?+MP[.^)X3'"88"/(WXVMU^ 6Y4M)<(*K,=C<HJ'_[
M,=VV4ZI!.UW=(V@N"Q)V05\;&KJSHDK45\?3N:SGGT[ZC:7GVFQC"N?6/BI[
MX[:S]FZ>&/YZ]2NF6K\O:K"<;Y%I^"^'V6[+1]N^..%;1]&?,@
M               3Y\>W +<WGYO)#@N+.DQG;O&_956ZNYSZ=\M+9Z![]$BC
MZ(V2LJ.UR4\*N371SET8QRIZ)Y_\^:;D.C_-O\69;92O&9]T1QGU;YA]!Z<]
M/=5YAUOY67\.77;>^&RL>^T\(]>Z)=@OQZX];4<7-J,8V9V9QB/&,*QB/2.-
M-'U==5O1/;5M;-HBS5,RIK)(OWD1$:C6IP$\P>8-5S356U&HMXKV]D1PB(X1
M'"/>_1/RYY<TG*M)73::OAI7VS/&9GC,\9]SFL\*\X
M
M
M
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MCHJO**MKV6Z-O>FBK3(U]4JM75CV1:_A($F6RTK
M                 XSWAV>VWW\VWRK:3=O%:;,\!S.F=37VQ5+5T<FJ.9+$
M]JH^*:)Z(^*5BH]CT1S51413R7*.;ZG0:FN?D6FN96<8F/VVQ/&-TP\7SGDV
MFYAIK:?45B^7>,)B?VV3&^)C;$[88'/)=XOMT. 6;I=Z9\V=<><OK)8]O-RV
MQJLM*]W=*RVW=(V-9#6-8BJUS?X.=J*]FBH^./G?TWZFZ7GV1X9^#45CXJ]O
MXJ]L?;&Z>$S^?75#I7JO+V?XH^/36GX;=GX;=EOLMOCC$59GT]\H
M               $U>"O!O=OG=O-;]M-NZ)]MQ>UO@J=T-R)HG.M^/6I\G:Z
M5Z]$DJ)4:YM-3HJ.D<B_@L:][/3//'G?2<BT<YV;.-IV5KQM/^$<9X>G")]X
M\@^0]9S_ %L9&3&%(VWMPK'OF>$<9[HF8["GC/QGVBXE;18YLOLOCC;#BEA;
MWU=6_MDK[K7R-:V>OKYVM:LU3,K4[G:(B(B,8C6-:U. 'F3S)J^;:NVHU%L;
MS[(CA$1PB/\ .=N,OT7\K^5]'R?1UTVFKX:5]LSQF9XS/^481$0Y]/ O80
M
M
M
M
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M75E4NK6KVZM;'$CDU;$QC5U5-2L2E,$
M         #X'=':[ -Z< RG:W=+%J7-,"S2E?1Y'CE8Q7PSPO5'(J*U4<R1C
MD1\<C%1['HCFJCD14[_E?--1HM17/R+37,K.,3'[>V-TQLEX_FO*M/KM/;(S
MZQ?+O&$Q/[;^R=\3MA@V\HWBNSK@3E[,OQ%]9G?&G+:CV6)YS*QKZNSU<B*Y
M+;=EA:UC9>B^QF1$9,U.B(]'-3G1TQZHY'/<G\O,PIJ:QMKPF/JKW=L;X]&U
MP ZK=)M1Y?SOS,O&^EM.RW&L_3;O[)W3Z<85%GUE\>
M   2ZX6\+=XN<F\5NVHVHMWL*2#V=3GN>U,;UM>.VM7]KJFI<W3N>[14AA1>
MZ5W1-$1SF^I><O.6CY)HYS\^=NZM8WVGLCWSNB/5#W'R1Y(UO/M;&GT\;-]K
M3NK';/NC?,^N8["KB7Q1VFX:[+XWLMM%:$I;7:6-FR+(Y61_C&_75\;6U%PK
MI&(G?+*K4T3\%C4:QB(QJ(G #S7YJU?.-9;49\XS.Z.%8X1'='VSMG:_1?RA
MY1T?)-#73:>,(C?/&T\;3WS]D;(V0DN>MO:
M
M
M
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MGSAWI8W2)-/X17F9E=F5D
M #Y#/L PK=/#,CV\W%QBCS/",NI7T>28Q<(6U%)5T\FBJU['_*BHCFN316N1
M'-5%1%.[T&OSM+G5S<FTUO6<8F-\.SYAR_(U>1;)SJQ?+M&$Q.V)AA/\K?BA
MR[@]EM3N;MA2UF7<7<KJE2S7A4?45F*U4[E<VW7)Z(JK&OHIJEW1Z>H]?:(B
MOYQ=+.JF5SO*_)SL*ZJL;8W1>/JKW]L<-\;-W ?JWTCSN0YWY^1$VTEIV3OF
MD_3;N[)X[IV[Z8S[&^)@                  E!Q#XC[N<U-Y['LOM!:VS7
M*L;\[R?):CN;;;%:(I61SU]8]J*J1L61K6M35SWJUC45RH>L^;?-FDY-HYU&
MHG9&R(XVGA$?MLC;+VKR=Y/UG/-=&FT\;9VS,[JUXS/=^^=D.PFX7<-=I.#N
MRUIV>VJI'U+E>E;F^:5+6I<<@O#XFQRU=1VJJ,31B-BB:O;&Q$1-5[G.X ^<
MO..KYWK9U&?Z*UC=6.R/?/&?8_1;R1Y*T?(=#&GR([[6G?:W;/NCA'M2U/4W
MN
M
M
M
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M.'?,S,S2/3'NX
M
M
M
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M_<KPK'OF>,^Z(A^BO3SI]I/+^BC*RHQS+83>_&T^ZL<(X>F9E.\]&>_@
M
M
M
M
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M(G;)"V:-E-3O3T]\$$;NOI*F*P,(
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M?9P?HCTTZ<:;R[H_!7"V=;;>_;/9'X8X1ZYWK%#YZ^D
M
M
M
M
M                 'SU1B.*5<\M55XQ;ZJIG<KYZB2BIGR/<JZJKG.8JJJ_
M=4#V-NM-JM$3X+3;*>UPRN[Y(:>&.!KG:(FJI$C45=$]('L
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MFM^*?9$;(XS/Z%]+^F&F\NZ7A?47CX[?RU[*Q[9G;/"(LZ/FCZF
M
M
M
M
M
M                         !_'-:]KFN:CFN14<U4U147IHNH&4_RD>"RJ
MNUPR7D+P@L,:U-8LU?G?'>!&Q(^5RK)+48\B(C45VJN6A71-=?8+U;"<I>F/
M7"*5KI.93NV5S/=?_J_YN,N)75;H)-[6UG*Z[9VVR_WS3_I_Y>%646[6BZV"
MZ7&QWVV5%EO=GGEI;O9ZN&2FJJ6I@>L4D4T4S6O8]CD5KFN1%14T4Y3Y6;3,
MK%JS$UG;$QMB8[G$C.R;Y=YK>)BT3A,3LF)[)AZ\ZCI@     2.XQ\3=^.7^
MX=)MKL1@M1E=W<L;KY>7(Z"T6:E>[M6IN-8YJQP1)HNFNKGJG:QKG:-7UWS+
MYKT/*-/.=J;Q6.$<;3V1'&?LCCA#V7RMY0YASG4QDZ6DVGC/RUCMM/"/MGA$
MRW8^.+Q@[0< L-^?TWL<^W[R:E;%GN[4T/:YL;^R1]OMD;]5IZ-KV(J_OY51
M'2+HC&,X.]1.IFKY]G83\&16?AI[[=L_9'#C,\^.FG2S1^7LC&/CU%H^*_\
M+7LK]L[YX1%GA\S?4P
M
M
M
M
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MR>Y+R+1\NR(R=-2,ND<(C[9XS/?.URH>+>6
M
M
M
M
M
M                  0.Y _^T6J_]$I?_F*>]<@_^OZY?/\ S'_]GU0D'Q^_
M]G5-_P"EU7_SD/7^?_\ V/5#V/R[_P#6CTRYN/"O.@
M
M
M
M
E                                             !__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo_pharmingxoriginala.jpg
<TEXT>
begin 644 logo_pharmingxoriginala.jpg
MB5!.1PT*&@H    -24A$4@  !58   '0" 8   !*GS'$    "7!(67,  "XC
M   N(P%XI3]V   @ $E$051XG.W=36]D5WHG^"N-&K9GQI/A;B\:SC$RC=D.
MD#0PP"RF!\F:^0"D%[E.)GAC+=8G$/4)1*TCB"37N1"YF84-M\@>5;OLME1D
ME>URHV4KT]4L=W655&2I+'5!.<[!29U0A4)\B1MQ[OOO!P2R2DI%W)>(^_*_
MSWG.*R]>O,@      )C?J[85     $ Q@E4     @(($JP      !0E6 0
M   *$JP"     !0D6 4     *$BP"@    !0D& 5     * @P2H     0$&"
M50    " @@2K       %"58!      H2K (     %"18!0     H2+ *
M %"08!4     H"#!*@    ! 08)5     (""!*L       4)5@$     "A*L
M @     4)%@%     "A(L H     4)!@%0    "@(,$J     $!!@E4
M@(($JP      !0E6 0     *$JP"     !0D6 4     *$BP"@    !0D& 5
M     * @P2H     0$&"50    " @@2K       %"58!      H2K (
M%"18!0     H2+ *     %"08!4     H"#!*@    ! 08)5     (""!*L
M      4)5@$     "A*L @     4)%@%     "A(L H     4)!@%0    "@
M(,$J     $!!@E4     @(($JP      !0E6 0     *$JP"     !0D6 4
M    *$BP"@    !0D& 5     * @P2H     0$&"50    " @@2K       %
M"58!      H2K (     %"18!0     H2+ *     %"08!4     H"#!*@
M  ! 08)5     (""!*L       4)5@$     "A*L @     4)%@%     "A(
ML H     4)!@%0    "@(,$J     $!!@E4     @(($JP      !0E6 0
M   *$JP"     !0D6 4     *$BP"@    !0D& 5     * @P2H     0$&"
M50    " @@2K       %"58!      H2K (     %"18!0     H2+ *
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M@WNQ[^J@ <L"    T$F"52BHX:'JA' 5    H$2"52@@SK[?]%!U0K@*
M4!(]5F%.@\W11I9ECUNXO?1<!0   $A,Q2K,H<6A:C95N;K2@&4!    Z 05
MJW"#EH>JTRYBY>I)<Q8)    H)U4K,(U.A2J!K=4K@(   "D(5B%*W0L5)T0
MK@(    DH!4 7&*P.5K/LNR=#F\;;0$     EB!8A1FQFO,H5G=VF7 5
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MMG:ER@Q5CVJ<H&I186*K57U7 0  @!14K%(ZH6HMA*K?="M6KJXT;<$   "
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M^@_9#__R@^Q/_I\_SMY__R3[KQ]_,M]__$T[<?] $;=BR/J]89X?A9LO6P\
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M\@A5YQ;"U9/!YFBE)<M+!4;C\7GBJM55^PT  & Y@M4&$JK6XK2,H.'!X=E
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M?@]3AJ"->Y ]+8XT2#VYHX(WDA.L5LN/N)BR0]64047K_/"'_U&HVF[Z>/7
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M%:H" '2&-@#0<(+5ANA!N"I4+4D(58_?^V[VRN>?=W+]>D:HRJ(.8Z6JX?\
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M5N_]]T^$JMTA5 7:2D4* '1'J@>=V@% "02K'29<K58(53\Y^W&?5KG+A*I
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M       %O6J# 0     4(U@%     "A(L H     4)!@%0    "@(,$J
M $!!@E4     @(($JP      !0E6 0     *$JP"     !0D6 4     *$BP
M"@    !0D& 5     * @P2H     0$&"50    " @@2K       %"58!
M  H2K (     %"18!0     H2+ *     %"08!4     H"#!*@    ! 08)5
M     (""!*L       4)5@$     "A*L @     4)%@%     "A(L H
M4)!@%0    "@(,$J     $!!@E4     @(($JP      !0E6 0     *$JP"
M     !0D6 4     *$BP"@    !0D& 5     * @P2H     0$&"50    "
M@@2K       %"58!      H2K (     %"18!0     H2+ *     %"08!4
M    H"#!*@    ! 08)5     (""!*L       4)5@$     "A*L @     4
M)%@%     "A(L H     4)!@%0    "@(,$J     $!!@E4     @(($JP
M    !0E6 0     *$JP"     !0D6 4     *$BP"@    !0D& 5     * @
MP2H     0$&"50    " @@2K       %"58!      H2K (     %"18!0
M   H2+ *     %"08!4     H"#!*@    ! 08)5     (""!*L       4)
M5@$     "A*L @     4)%@%     "A(L H     4)!@%0    "@(,$J
M $!!@E4     @(($JP      !0E6 0     *$JP"     !0D6 4     *$BP
M"@    !0D& 5     * @P2H     0$&"50    " @@2K       %"58!
K  H2K (     %"18!0     H(LNR_Q_*&R%AGG2J-P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
